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ABSTRACT 
A study on tumour suppressor gene methylation in placental tissues 
A thesis submitted by YUEN Ka Chun for the degree of Master of Philosophy in 
Chemical Pathology at The Chinese University of Hong Kong in August 2007 
The pseudomalignant nature of the placenta has long been suggested. Analogies 
between placental tissues and malignancies have been drawn mainly in terms of their 
morphologies and proto-oncogene expression patterns. It has recently been 
demonstrated that a tumour suppressor gene (TSG), Ras association domain family 1 
{RASSFIA), is hypermethylated, a phenomenon that is widely reported in cancer, in 
human and rhesus placentas. These observations implicated that the 
pseudomalignancy analogy might extend to an epigenetic level. This thesis aims to 
explore the epigenetic similarity between placental tissues and malignancies by 
searching for placental hypermethylation of TSGs. Moreover, the biological and 
phylogenetical significance of placental hypermethylation in selected primate and 
non-primate placentas was investigated. 
The first part of this thesis focuses on the search of hypermethylated TSGs in term 
human placentas. Methylation-specific polymerase chain reaction (MSP) was used to 
amplify the methylated DNA sequences in the promoter regions of TSGs and 
non-TSGs from third-trimester placental tissues and their corresponding maternal 
buffy coats. After validation by sodium bisulfite sequencing in the first- and 
third-trimester placental tissues, 5 out of 46 TSGs were found to be methylated in the 
placenta only, while none of the 15 non-TSGs was found to show placenta-specific 
methylation. A panel of fetal tissues collected from abortuses were surveyed by 
quantitative-MSP (QMSP) and revealed that the TSG hypermethylation was a 
i 
placental-specific phenomenon. 
The biological significance of the hypermethylated TSGs was further studied in the 
second part of the thesis. The possibility of genomic imprinting for adenomatosis 
polyposis coli (AFC) was explored by looking for evidence of allele-specific 
methylation. Treatment of choriocarcinoma cell lines, JAR and JEG3, by 
5-aza-2‘deoxycytidine and trichostatin A led to reduction in methylation but increased 
expression of AFC. This finding suggested a relationship between the expression and 
the promoter methylation of AFC. The biological significance of AFC 
hypermethylation in primate placentas was also supported by the conservation of APC 
promoter hypermethylation in placentas from the rhesus monkey but not the mouse. 
The epigenetic conservation of APC hypermethylation in human and rhesus placentas 
led us to the exploration of the evolutionary trends in epigenetic processes among 
mammals. In the last part of this thesis, the methylation status of six TSGs: AFC, 
caspase 8 {CASP8), DAB2 interacting protein (DAB2IP)’ secretoglobin, family 3A 
member 1 {SCGB3A1), protein tyrosine phosphatase non-receptor type 6 {PTPN6) 
and maspin {SERPINB5), were studied in the placentas of the rhesus monkey and 
mouse. The tissue-specific patterns of methylation for APC were conserved between 
human and the rhesus monkey. These findings suggested that epigenetics may add 
another dimension to the study of species evolution. 
The results presented in this thesis have extended the analogy between primate 
placentas and malignant tumours to an epigenetic level and offered evidence 
suggesting the biological significance and important evolutionary roles of 
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SECTION I: BACKGROUND 
1 
Pseudomalignant nature of the placenta 
CHAPTER 1: Pseudomalignant nature of the placenta 
1.1 Overview 
The human placenta is a normal tissue present in a pregnant female during gestation. 
It serves as an interface between the mother and the fetus. It is crucial for a successful 
pregnancy since it mediates the fetal development by providing a continuous nutrient 
source to the fetus and removing waste from the fetus. To increase the efficiency of its 
functions, the placenta has to increase the surface area of contact between fetal and 
the maternal circulations. In the human, it is achieved by the complex villous structure 
derived from the placenta to penetrate the mother's uterus in search of maternal blood 
supply (Kliman 2000, Staun-Ram and Shalev 2005). The development of villous 
structure involves rapid proliferation (Bischof et al. 2001), the ensuing invasion of 
mononuclear trophoblast cells into the uterus and the remodelling of the spiral arteries 
(Red-Horse et al 2004). The high cell proliferation, migratory and invasive properties 
have led to the statement of the trophoblast as a 'pseudo-malignant' type of tissue 
(Strickland and Richards 1992). In fact, many other similarities exist between embryo 
implantation and the growth of cancer cells. Apart from the rapid proliferation and 
invasive nature, analogies have been drawn between placental tissues and tumour 
cells in terms of their gene expression profiles (Janneau et al. 2002), especially with 
regard to activation of angiogenic factors (Murray and Lessey 1999, Zhou et al 2003), 
growth factors and proto-oncogenes (Ohlsson 1989). 
Trophoblast cells utilize many of the same molecular mechanisms as those of tumours 
for their growth, migratory and invasive functions. The human placenta can thus be 
regarded as a physiological counterpart of invasive malignant tumours. However, the 
comparison ends here, since the placenta knows precisely when to stop growing. 
2 
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What sets the trophoblast cell apart from a malignant cell is that its activation of 
growth factors and proto-oncogenes is only temporary and reversible (Soundararajan 
and Rao 2004). In contrast, the rapid cell proliferation and invasive nature of 
malignant cells are driven by point-mutations or translocations of proto-oncogenes 
which causes some of the involved genes to become aberrantly expressed. Fortunately, 
the tumour-like attributes of human trophoblast cells are only transient in nature 
(Soundararajan and Rao 2004). This is an important regulatory feature that checks the 
proliferative potential of these otherwise tumour-like cells. 
1.2 Proliferation, migration and invasion behaviour 
The placenta is comprised of specialized epithelial cells called trophoblasts. There are 
two broad types of trophoblast cells: cytotrophoblasts and syncytiotrophoblasts. 
During implantation, the blastocyst invades the decidua of the uterine wall and the 
trophoblast cells become invasive as they differentiate (Staun-Ram and Shalev 2005). 
The cytotrophoblast stem cells attach to the trophoblast basement membrane and 
actively proliferate. The cytotrophoblasts then fuse to form multinucleate 
syncytiotrophoblasts, which form the outer layer of the chorionic villi responsible for 
directly contacting the maternal blood for nutrient and gas exchange of the fetus 
(Kliman 2000). On the other hand, a subset of proliferative cytotrophoblast cells 
differentiates into proliferative extravillous cytotrophoblasts which are responsible for 
the penetration of the uterine wall (Staun-Ram and Shalev 2005). The behaviour of 
these extravillous cytotrophoblasts closely resembles that of transformed cells that 
display a tumourigenic phenotype after neoplastic transformation. This transformation 
is accomplished by localized tumours in the absence of metastasis (Gupta et al. 2005). 
3 
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As the cytotrophoblasts further differentiate, they can develop into migratory and 
invasive extravillous cytotrophoblasts. At this stage, they lose the ability to divide and 
become mobile and invasive. The extravillous cytotrophoblasts will colonize and 
invade the decidualized endometrium and myometrium (Burrows et al. 1996). The 
behaviour of these invasive extravillous cytotrophoblasts resembles the transformed 
cells that display a metastatic phenotype after malignant transformation (Poste and 
Fidler 1980). The migration and invasion abilities of these extravillous 
cytotrophoblasts are shared by all metastatic tumours and they are not caused by 
passive growth pressure, but due to an active process. It involves basement membrane 
attachment followed by detachment and proteolysis before its penetration (Liotta 1984, 
Staff2001). 
Despite the striking similarities between the trophoblasts and tumour cells, they are 
different in important ways. While tumour cells possess extensive and apparently 
unregulated proliferation, the proliferation of extravillous cytotrophoblasts is tightly 
regulated and these cells stop growing during invasive differentiation (Pollheimer and 
Knofler 2005). Also, the migratory and invasive capacities of invading extravillous 
cytotrophoblasts cells are spatially and time regulated. When the capacities are kept 
under control, they enable the accomplishment of successful embryo implantation and 
pregnancy progression. When such capacities are no longer kept under control, 
neoplastic and malignant transformation would result in invasive tumours like 
choriocarcinoma (Baergen 1997). 
1.3 Gene expression 
The analogous behaviours of normal cytotrophoblasts and cancer cells originate from 
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their individual genetic programmes. Thus, it is not surprising to find that their 
expression of genes which are responsible for proliferative, migratory and invasive is 
highly similar (Janneau et al. 2002). Examples of these genes are angiogenic factors, 
growth factors, proto-oncogenes as well as several tumour suppressor genes. 
1.3.1 Angiogenic factors 
Angiogenesis is a physiological process involving the growth of new blood vessels 
from pre-existing vessels. Angiogenesis of tumour cells can be initiated by basic 
fibroblast growth factor (bFGF) or by vascular endothelial growth factor (VEGF). 
Both VEGF and bFGF are very potent initiators of angiogenesis (Poon et al. 2003). 
These factors can signal the nearby vessels to send out new branches (Norrby 1997). 
It is found that human trophoblast cells can also release cytokines that include bFGF 
(Hamai et al 1998). Besides, VEGF mRNA and protein are found to be localized in � 
endometrial macrophages, as well as in the stroma and glandular epithelium during 
embryo implantation (Chamock-Jones et al. 1993, Li et al 1994). The released VEGF 
can then bind to the VEGF receptor expressed in invading human cytotrophoblast 
cells (Clark et al. 1996). Once the VEGF receptor is activated, it will stimulate the 
production of factors that variously stimulate vessel permeability, proliferation, 
migration and finally differentiation into mature blood vessels. 
1.3.2 Growth factors 
Growth factors are important for cell proliferation. They are required for signalling the 
normal cells to move from a quiescent state into an active proliferative state. There are 
different classes of signalling molecules. For example, diffusible growth factors, 
extracellular matrix (ECM) components and cell-to-cell adhesion/interaction 
5 
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molecules (Hanahan and Weinberg 2000). These signals are transmitted to the cell by 
transmembrane receptors. It is known that excessive production of these classes of 
molecules can lead to the expression of a transformed phenotype. Many of these 
growth factors are similarly expressed by the normal trophoblasts and malignant 
non-trophoblastic tumour cells. Examples are epidermal growth factors (EGFs) 
(Ladines-Llave et al. 1991), colony-stimulating factor (CSFl) (Hamilton et al. 1998), 
transforming growth factor- a (TGF- a ) (Horowitz et al. 1993), TGF-B (Dungy et al 
1991), insulin-like growth factor (IGF) (Maruo et al. 1995), in particular IGF-2 
(Ohlsson et al. 1989), placental growth factor (PIGF) (Maglione et al. 1993), vascular 
endothelial growth factor (VEGF) (Clark et al. 1996), erythropoietin (Conrad et al. 
1996) and PDGF-like protein (Goustin et al. 1985). 
1.3.3 Proto-oncogenes 
Proto-oncogenes are normal cellular genes homologous to the viral oncogenes that can 
induce cancer. Proto-oncogenes, once activated, become oncogenes that are also 
capable of inducing neoplasia (Karamouzis et al. 2002). Activation occurs through 
various mechanisms such as mutations, gene amplifications or chromosome 
rearrangements (Anderson et al. 1992). Proto-oncogene products are responsible for 
essential processes, including cell proliferation, migration and invasion. They play an 
important role in the cause of cancers since their transcription is one of the first steps 
leading to malignant cell transformation (Bishop 1987). The similarity between 
trophoblastic cells and transformed cells prompted investigators to study the 
distribution of proto-oncogenes in the human placenta and they could also find 
similarity of their expression of proto-oncogenes 
In cancer, many oncogenes act by mimicking normal growth signalling (Hahn and 
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Weinberg 2002). Similarly, several proto-oncogenes encoding growth factor receptors 
are expressed by trophoblast cells. Among different proto-oncogenes, MYC, JUN, 
FOS, EGFR, CSFIR, KDR, PDGF and RAS are common examples that their 
expression can be found in both normal trophoblasts and cancer cells. FOS, JUN and 
MYC are the proto-oncogenes that code for transcription factors. They are expressed 
by extravillous cytotrophoblasts in the placenta (Goustin et al 1985, Quenby et al. 
1998). MYC is essential for cell cycle. Similar to many actively dividing cancer cells, 
MYC expression was found to be critical for early trophoblast proliferation 
(Pfeifer-Ohlsson et al 1984). Fos and Jun are expressed at the appropriate time and 
place in trophoblast cells so as to stimulate trophoblast invasion during the 
development of the placenta (Bischof et al. 2001). EGFR, CSFIR, KDR code for 
growth factor receptors: EGF-R, M-CSF-R and VEGF-R respectively. EGF-R is 
responsible for cell proliferation (Filla and Kaul 1997). M-CSF-R has been correlated 
with trophoblastic invasiveness and the metastatic phenotype (Bischof and Campana 
1997). VEGF-R can be bound by the growth factor VEGF to affect cell proliferation, 
invasion and other metabolic activities in the cell (Shore et al 1997). The PDGF 
proto-oncogene is transcribed in early placenta at levels comparable with transcription 
in human tumour cell lines actively producing PDGF (Goustin et al. 1985), and the 
maximal levels of PDGF transcripts are found in particularly active and invasive 
extravillous cytotrophoblasts cells (Goustin et al. 1985). RAS codes for RAS proteins 
that play an essential role in controlling the activity of several crucial signalling 
pathways that regulate cellular proliferation (Downward 2003, Malumbres and 
Barbacid 2003). 
All these proto-oncogenes interact in a complex, only partially elucidated way to 
control cellular proliferation, migration and invasiveness, and it is remarkable that 
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each type of trophoblast expresses a subtly different combination of proto-oncogenes 
(Quenby et al. 1998). Moreover, it is noteworthy that several of those 
proto-oncogenes, including EGFR, MYC, PDGF and HRAS, are preferentially 
expressed by trophoblast cells during the first weeks of pregnancy, a time at which the 
proliferative, migratory and invasive properties of these cells are at their peak. 
1.3.4 Tumour suppressor genes 
The expression of tumour-suppressor genes have also been investigated in trophoblast. 
Since the placenta is considered to be a "well-behaved" tumour, it is not surprising 
that several tumour suppressor genes may act to regulate the invasion of the 
trophoblast during development. The TP53 is one of the tumour suppressor genes that 
found to be associated with the development of the placenta. P53 is a nuclear 
phosphoprotein involved in tumour progression. The wild type p53 is an inhibitor of 
cell proliferation and differentiation whereas the mutated p53 is oncogenic (Bishop 
1991) In fact, p53 mutation is the most common genetic change related to cancer. 
Overexpression of p53 inhibits oncogene induced transformation of cells, while the 
mutated form of p53 has lost this property and becomes oncogenic. These properties 
make p53 an excellent candidate as a potential regulator of trophoblast invasion 
particularly since villous and extra villous cytotrophoblast and villous 
syncytiotrophoblast express the wild type p53 (Haidacher et al. 1995，Marzusch et al. 
1995, Aboagye-Mathiesen et al. 1996) whereas the choriocarcinoma cell lines JAR, 
Be Wo and JEG express mutated p53 (Aboagye-Mathiesen et al. 1996). 
Another tumour suppressor gene extensively investigated in the placenta is the 
retinoblastoma 1 {RBI) gene. RBI was the first tumour suppressor gene identified in 
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cancer (Murphree and Benedict 1984). Recently, a study showed that the loss of RBI 
can lead to excessive proliferation of trophoblast cells and a severe disruption of the 
normal labyrinth architecture in the placenta (de Bruin et al 2003). It is found that the 
function of RBI in extra-embryonic cell lineages is for embryonic development and 
viability (Wu et al. 2003). 
Remarkably, TP53 and RBI are differentially expressed in particular periods during 
placental development (Roncalli et al. 1994, Quenby et al. 1998, Soloveva and Linzer 
2004). Changes in TP53 and RBI metabolism are closely coupled to changes in other 
cell cycle regulatory components, so that instead of becoming a hyperproliferative cell, 
the trophoblast cell enters into a terminally differentiated, non-proliferative cell fate. 
This perhaps once again explained the transient tumour nature of the placenta 
(Soloveva and Linzer 2004). 
Recently, another tumour suppressor gene, RASSFIA, was found to be 
hypermethylated in the placenta of human and the rhesus monkey. RASSFIA is a 
member of a group of RAS effectors thought to regulate cell proliferation and 
ap opto sis (Agathanggelou et al. 2005). This gene is silenced and frequently 
inactivated by promoter region hypermethylation in many adult and childhood cancers 
(Agathanggelou et al. 2005). The hypermethylation of RASSFIA has been reported in 
at least 37 tumour types (Agathanggelou et al. 2005). Although the function of 
RASSFIA in the placenta is still unknown, the striking similarity of the placenta and a 
tumour tissue at the epigenetic level demonstrated by this gene has certainly opened 
up an interesting direction for pseudomalignancy studies. 
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CHAPTER 2: Epigenetics 
2.1 Overview 
DNA is the prime macromolecule that stores genetic information (Watson and Crick 
1953), and it propagates this stored information to the next generation through the 
germ line. However, because all of the cells in the body inherit the same DNA 
sequences, the complex cellular differentiation processes cannot be explained merely 
by widespread somatic mutation on DNA sequences. Thus, a concept of epigenetics 
has emerged. The definition of epigenetics is: "the study of mitotically and/or 
meiotically heritable changes in the gene function that cannot be explained by 
changes in DNA sequence" (Russo et al. 1996). 
Epigenetics involves changes in DNA and chromatin structure that are remembered 
by the cell when it divides. Examples are DNA methylation and histone modification. 
Many of these modifications and changes are reversible but stable. They can be 
inherited through multiple cell divisions and therefore constitutes a form of cellular 
memory. Among different epigenetic phenomena, DNA methylation is the most 
studied (Holliday 2005). 
DNA methylation consists of the addition of a methyl group at cytosine residues of 
the DNA template. In mammals, methylation occurs predominantly at the fifth 
position of cytosine (m5C) of the symmetrical CpG dinucleotides. Other than 
mammals, cytosine methylation can also be found in the invertebrates such as 
Drosophila melanogaster (Achwal et al. 1984) and Ciona intestinalis (Simmen et al. 
1999). The cytosine methylation found in these animals can occur in CpG 
dinucleotides or non-CpG dinucleotides (Lyko et al. 2000). The variety of DNA 
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methylation patterns in different animals suggests that different distributions reflect 
different functions of the DNA methylation system (Colot and Rossignol 1999). In 
this thesis, I will focus on the study of CpG methylation in mammals. 
2.2 DNA methylation in mammals 
In the mammalian genome, around 70% of CpG dinucleotides are methylated (Ehrlich 
et al. 1982) and these CpG dinucleotides are actually under-represented in much of 
the genome. Exceptions to this global methylation are the short regions of 0.5-4kb in 
length, known as CpG islands (Bird 1986). They are unmethylated GC-rich regions 
that possess high relative densities of CpG and are mostly positioned at the 5' ends of 
mammalian genes (Bird 1986). 
DNA methylation patterns show apparent overall constancy when different somatic 
cell types are examined, but local changes are evident at specific DNA sequences 
during development. For example, CpG islands on one X chromosome become de 
novo methylated in large numbers during the embryonic process of X-chromosome 
inactivation in female placental mammals (Wolf et al. 1984). The somatic DNA 
methylation patterns of mammals are largely determined by the cycle of early 
embryonic demethylation followed by de novo methylation. 
The factor that determines the part of DNA sequences to be methylated or 
unmethylated in the mammalian genome during development remains largely 
unknown at present. However, it is known that the process is mainly catalyzed by the 
enzymes called DNA methyltransferases (DNMTs). 
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2.3 Regulation of DNA methylation machinery 
The process of methylation is mediated by at least three DNMTs — DNMTl, 
DNMT3a and DNMT3b. They are responsible for catalyzing the transfer of a methyl 
group from a methyl donor, S-adensoyl-L-methionine, to the cytosine. Although some 
other DNMTs like DNMT2 (Yoder and Bestor 1998) and DNMT3L (Aapola et al 
2000) have been discovered, their roles in methylation process are still uncertain. 
DNMTl is ubiquitously expressed and is a maintenance methyltransferase. It prefers 
to methyl ate the hemi-methylated CpG sites after DNA replication (Bestor et al. 1992, 
Pradhan et al. 1999). Therefore, the methylation pattern between cell generations can 
be maintained. DNMT3a and DNMT3b are regulated during development and are 
required to initiate de novo methylation and establish new DNA-methylation patterns 
(Hsieh 1999, Okano et al. 1999). 
Little is know about the mechanism by which a DNA methylation pattern is 
established. However, several hypotheses have been proposed. For example, it is 
suggested that DNA methylation patterns are determined by the modification state of 
the underlying chromatin (Selker 1990). This theory implies that DNA methylation is 
only a secondary process which is triggered by an earlier decision to modify histone 
proteins in specific ways. The idea is supported by the evidence that DNA 
methylation is dependent on the presence of methylation of histone H3 on lysine 9 
(H3K9me) (Tarnam and Selker 2001). However, so far the report of this linkage is 
only seen in the invertebrates. Another attractive hypothesis is that RNA interference 
(RNAi) is the trigger for de novo methylation. RNA-directed gene methylation is a 
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common phenomenon in plants (Aufsatz et al 2002). Recently, a study of the 
a-globin gene, HBA2, in mouse supported that RNA-directed DNA methylation can 
also occur in mammals (Tufarelli et al 2003). De novo methylation triggered by 
RNAi has also been reported in cultured mammalian cells (Kawasaki and Taira 2004). 
However, the phenomenon is less clear-cut than in plants. Apparently, there is no 
single model that can fully explain the complex DNA methylation mechanism thus 
far. 
2.4 Role of DNA methylation 
It is believed that the main function of methylation is to maintain genes in a 
transcriptionally silent state. Studies in mammals have linked patterns of DNA 
methylation to gene expression (Jackson-Grusby et al. 2001). It is particularly 
important to maintain undesirable elements, like repeat elements and transposons, in a 
transcriptionally inert state because transcription of these elements might harm cells 
(Yoder and Bestor 1998). Therefore, the portion of DNA in these non-coding regions 
is heavily methylated. 
The detailed mechanism of DNA methylation-mediated transcriptional repression is 
not yet resolved. However, it is generally believed that gene silencing involves the 
methylation of CpG islands in the gene promoter region. One of the well accepted 
models involves the binding of transcriptional repressor proteins called 
methyl-CpG-binding proteins (MBPs). Four MBPs — MBDl, MBD2, MBD3 and 
MeCP2 — have been implicated in association with methylated cytosine and various 
chromatin-remodelling complexes (Bird and Wolffe 1999). They have also been 
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shown to compete efficiently with sequence-specific DNA-binding transcriptional 
factors for the same promoter when these sequences are methylated (Bird and Wolffe 
1999, Leonhardt and Cardoso 2000). Methylation might also influence transcription 
indirectly through chromatin condensation, which is the packing of DNA into higher 
order three-dimensional protein-nucleic acid structures, often associated with gene 
inactivation. This presents a method by which the MBPs might recruit histone 
deacetylases (HDACs) to methylated DNA and alter the accessibility of DNA to 
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Figure 2.1. Effects of DNA methylation on gene transcription 
Upper panel: Before DNA methylation, the promoter region in the CpG island is 
accessible to key components of the gene-transcription apparatus, including primary 
transcription factors (TF), histone acetyltransferase activity (HAT) and 
transcriptional coactivators (CA). 
Lower panel: After DNA methylation, the apparatus for DNA methylation, 
consisting of the DNA methyltransferases (DNMTs) and their complexes with 
transcriptional corepressors (CR) and histone deacetylases (HDAC) have access to 
the CpG island of the promoter region which causes transcriptional repression by 
recruiting methylcytosine-binding proteins (MBPs) to the DNA methylated sites so 
that the nucleosomes are more tightly compacted, histories are deacetylated and 
lysine 9 residues on the tails of histone H3 are methylated. The transcriptional 
machinery is now excluded. 
Modified from "DNA methylation and gene silencing in cancer" (Baylin 2005). 
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2.5 Aberrant DNA methylation 
Many diseases have been linked to aberrant DNA methylation. Among these, cancer is 
one of the best studied one. The aberrant DNA methylation of cancer can be divided 
into two categories: global demethylation and tumour suppressor gene 
hypermethylation. 
Global hypomethylation in tumour cells is primarily due to the loss of methylation 
from the repetitive regions of the genome (Yoder et al 1997). As previously 
mentioned, repetitive regions are normally methylated in the mammalian genome. 
However, these regions are observed to be hypomethylated in the tumour cells and the 
resulting genomic instability is a hallmark of tumour cells. The demethylation of 
transposon promoters might contribute to aberrant gene regulation in cancer by 
transcriptional interference or generation of antisense transcripts (Robertson and 
Wolffe 2000). Strong support for hypomethylation leading to activation of genes that 
are important in cancer includes promoter CpG demethylation in the overexpression 
of cyclin D2 (Oshimo et al 2003) and SERPINB5 in gastric carcinoma (Akiyama et al 
2003) and S100A4 in colon cancer (Nakamura and Takenaga 1998). Global 
demethylation early in tumourigenesis might predispose cells to genomic instability 
and further genetic changes, whereas gene-specific demethylation could be a later 
event that allows tumour cells to adapt to their local environment and promotes 
metastasis. 
Another way in which DNA methylation can contribute to cancer is the tumour 
suppressor gene hypermethylation. Aberrant hypermethylation in cancer usually 
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occurs at the CpG islands. As mentioned previously, CpG islands are usually 
unmethylated in normal somatic cells (Song et al 2005). The aberrant methylation 
results in changes in chromatin structure which effectively silences transcription. To 
date, aberrant methylation of promoter CpG islands is the most commonly studied 
epigenetic mechanism associated with the transcriptional silencing of known and 
suspected tumour suppressor genes. It is shown that methylation-associated silencing 
inactivates certain tumour suppressors as effectively as mutations and is one of the 
cancer-predisposing hits described in the classical Knudson's two hit hypothesis 
(Esteller et al. 2000a). Aberrant methylation of normally unmethylated 5'-CpG-rich 
areas has been demonstrated in RBI (Ohtani-Fujita et al. 1993) RASSFIA (Dammann 
et al. 2000), APC (Esteller et al. 2000b), BRCAl (Magdinier et al. 2000) etc. The 
silencing of tumour suppressor genes provides tumour cells with a growth advantage 
and allows them to metastasize. 
2.6 DNA methylation in normal cells 
Despite playing an important role in the control of gene expression in tumour cells, 
DNA methylation can also play a role in normal cells. For some sets of genes, there is 
a clear correlation between CpG island methylation and transcriptional inactivation in 
normal cells. 
2.6.1 X-chromosome inactivation 
In mammals, females contain two copies of the X chromosome while males contain 
only a single copy. X chromosome inactivation is a process by which one of the two 
X chromosomes present in female is inactivated randomly in order to overcome the 
problem of dosage compensation during early development. Compared to active 
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chromosome (Xa), the inactivated X chromosome (Xi) possesses a high level of 
methylation in CpG islands which is associated with gene silencing (Heard et al. 
1997). The importance of methylation on gene silencing on the X chromosome can 
also be found in the pseduoautosomal region, where the genes escape inactivation. 
The CpG islands of the genes found in pseudoautosomal region remains unmethylated 
on both the active and inactive chromosomes (Heard et al. 1997). Treatment of cells 
with inhibitors of methylation results in re-activation of previously silenced genes on 
the Xi (Hansen et al. 1996). This further demonstrates the role of DNA methylation of 
CpG islands in the maintenance of inactivation within the Xi. In addition, DNA 
methylation may also play a role in the initiation of X-chromosome inactivation 
(Boumil and Lee 2001). 
2.6.2 Genomic imprinting 
Mammals are diploid organisms whose cells possess two matched sets of 
chromosomes. Genomic imprinting is a phenomenon that the cells will express only 
one parental copy of an imprinted gene and silence the other parental copy 
(Bartolomei and Tilghman 1997). A number of mammalian genes are known to be 
imprinted. DNA methylation can perform two different functions in genomic 
imprinting. It can act as the imprinting mark by being acquired de novo only by the 
chromosome of one gamete. It can also serve to silence one of the parental alleles 
since DNA methylation is associated with gene repression. The regions where 
imprinted genes associated with DNA methylation are called differentially methylated 
regions (DMRs) (Paulsen and Ferguson-Smith 2001). It is one type of allele-specific 
methylation which DNA is methylated according to parent of origin. Parental 
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allele-specific DNA methylation has been found at most imprinted clusters that have 
been examined. 
DMRs can be found in promoter regions or non-promoter regions to perform its 
silencing effect. For example, the DMR of Igf2 is not located in its promoter region. 
Rather, it is located upstream of the H19 promoter, which is methylated only in the 
paternal gamete and is maintained thereafter in all somatic tissues (Bartolomei et al. 
1993, Ferguson-Smith et al 1993). Examples of imprinted genes with DMRs are in 
the promoter region include Igftr, Pws, Kcnql, Gnas, and Dlkl (Pauler and Barlow 
2006). 
2.6.3 Cell-type-specific methylation 
X chromosome inactivation and genomic imprinting are two examples that CpG 
islands can be methylated in normal cells but their methylation pattern is identical in 
all somatic cell types. CpG island methylation was not generally believed to be 
involved in tissue- or cell-type-specific gene expression. However, it has recently 
been demonstrated that cell-type-specific CpG island methylation does exist in some 
of the genes and it is critical in regulating their cell-type-specific expression patterns. 
SERPINB5 is the first clear example of cell-type-specific methylation (Futscher et al. 
2002). SERPINB5 was identified by sub tractive hybridization analysis of normal 
mammary tissues and breast cancer cell lines (Zou et al 1994). It is known to be 
unmethylated in normal breast cells and frequently hypermethylated in breast cancers 
(Domann et al. 2000). However, further studies in normal cells found that, although 
SERPINB5 was unmethylated and expressed in cells of epithelial origin, it was 
methylated in mesenchymal and haematopoietic cells where expression was repressed. 
Further, it was demonstrated that methylation was required for transcriptional 
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repression (Futscher et al. 2002). Later, the same group identified another gene which 
undergoes cell-type-specific methylation, 14-3-3(5 (Oshiro et al 2005), which exhibits 
a very similar pattern of CpG island methylation and expression as SERPINB5. Its 
methylation has been identified in both fibroblast and haematopoietic cells (Oshiro et 
al. 2005). 
Subsequently, several other genes with cell-type-specific CpG island methylation 
were discovered by other groups. One of the examples is methylation-controlled 
DNAJ (MCJ) (Strathdee et al. 2004a). MCJ was originally identified as a gene 
frequently hypermethylated in ovarian cancer and was implicated in chemotherapeutic 
drug resistance (Shridhar et al. 2001). On the contrary to SERPINB5, MCJ gene 
exhibits CpG island methylation and transcriptional repression in epithelial cells and 
is expressed and unmethylated in mesenchymal and haematopoietic cells (Strathdee et 
al. 2004a). Another gene exhibit cell-type-specific CpG island methylation is the 
HOXA5 gene, a member of the HOX gene family that plays key roles in embryonic 
development and in differentiation of adult cells. It exhibits CpG island methylated 
specifically in mesenchymal and haematopoietic cells (Strathdee et al 2007). 
Little is known about the mechanisms of cell-type-specific DNA methylation 
regulation. However, it is recently demonstrated that the patterns of histone 
modifications following the methylation of MCJ and H0XA5 are unlike those 
observed in imprinted genes or genes hypermethylated in cancer (Strathdee et al 
2007). This observation suggests that specific pathways may exist for the 
interpretation of DNA methylation signals on these genes. 
2.6.4 Placental-specific methylation 
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The placenta is known as an organ with a low overall methylation content (Rossant et 
al 1986, Monk et al. 1987). However, placental-specific gene methylation patterns do 
exist in mammals and some of them have even found to be associated with placental 
development. 
A genome-wide study of methylation status in the rat placenta has discovered 10 loci 
that are specifically methylated in the placenta (Ohgane et al 1998). Further 
investigation confirmed the placental-specific methylation of Oct-4 (Hattori et al. 
2004) and Nanog (Hattori et al. 2007). However, the methylation of these genes has 
only been demonstrated in the rat thus far. CIITA is another gene with 
placental-specific methylation reported, but the evidence is shown in cell lines only 
(Morris et al. 2002). 
Recently, promoter hypermethylation of the RASSFIA tumour suppressor gene was 
identified in the human placenta (Chin et al. 2007). Unlike the other genes exhibiting 
placental-specific methylation mentioned, the hypermethylation of RASSFIA could be 
found in all three trimesters of pregnancy with no apparent inter-individual difference 
(Chill et al. 2007) It was also demonstrated that the hypermethylation was only 
observed in the placenta, but not in any other tissues examined (Chiu et al. 2007). 
These observations not only suggested a possible role for RASSFIA in placenta 
biology, but also implied that similar observations may extend to other known tumour 
suppressor genes. 
2.7 Aim of Thesis 
The discovery of RASSFIA hypermethylation in the placenta suggested a possible role 
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of tumour suppressor genes hypermethylation in placental biology. This thesis aims to 
address the analogy of the placenta and a tumour tissue at the epigenetic level. 
In the first part of thesis, the possible existence of hypermethylation in tumour 
suppressor genes other than RASSFIA in the placenta is investigated. A search for 
hypermethylation in the currently known tumour suppressor genes in the placenta is 
carried out in chapter 4. The characteristic of the hypermethylation in human tissues is 
further investigated in chapter 5. 
The function of the TSG hypermethylation is discussed in the second part of the thesis. 
In chapter 6, the hypermethylation is studied for the possibility of genomic imprinting. 
In chapter 7, the regulatory role of TSG hypermethylation is investigated. 
Finally, chapter 8 will study for cross species comparison of TSG hypermethylation in 
the placenta. The general conclusion and the future prospects regarding the findings in 
these TSG hypermethylation studies in the placenta are then discussed in the last 
chapter. 
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CHAPTER 3: Materials and methods 
3.1 Preparation of samples 
3.1.1 Collection of placental tissues 
Pregnant women with uncomplicated pregnancies who attended the Department of 
Obstetrics and Gynaecology at the Prince of Wales Hospital, Hong Kong were 
recruited with informed consent. The study and the collection of human clinical 
samples were approved by the Joint Chinese University of Hong Kong - New 
Territories East Cluster (CUHK-NTEC) Clinical Research Ethics Committee. 
First-trimester placental tissues were collected immediately after elective pregnancy 
terminations. Second trimester fetal tissue biopsies were obtained from two fetuses 
aborted spontaneously and confirmed to be karyotypically normal. Third-trimester 
placental tissues were collected after elective caesarean deliveries. A piece of 
placental tissue of approximately one cubic centimetre was dissected within three 
centimetres diameter from the umbilical cord so as to avoid any maternal decidua 
contamination. The placental tissues were cut into small pieces, rinsed in 
diethylpyrocarbonate (DEPC)-treated water and stored in plain polypropylene tubes at 
-20°C until DNA extraction. 
Murine placental tissues (El8.5) were obtained from pregnant mice (ICR) at the 
Laboratory Animal Services Centre of The Chinese University of Hong Kong with 
institutional animal ethics approval and were sacrificed near term. Among the seven 
placentas collected, two were bisulfite sequenced individually and the remaining five 
were pooled before bisulfite sequencing. Rhesus tissues were obtained from the 
Guangdong-Zhaoqing Laboratory Animal Research Center in China using procedures 
stipulated by the Convention on International Trade in Endangered Species of Wild 
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Fauna and Flora and the animal ethics committee at The Chinese University of Hong 
Kong. Pregnant rhesus monkeys were sacrificed near term. Peripheral blood samples 
were collected from the two pregnant rhesus monkeys. Placenta, liver, and heart 
tissues were collected from the fetuses of each pregnancy. 
3.1.2 Preparation of blood cells 
Maternal peripheral blood samples (12 mL of EDTA) were collected just before the 
performance of obstetrics procedures. All pregnant women participating in this study 
had given consent for the use of their biological specimens for research purpose. 
Ethics approval had also been obtained from the Joint CUHK-NTEC Clinical 
Research Ethics Committee. Blood samples were centrifuged at 1600 g for 10 minutes 
at 4°C (Centrifuge 581 OR; Eppendorf). Plasma was carefully removed to ensure that 
the blood cell portion was undisturbed. The peripheral blood was recentrifuged at 
2500 g for 5 min (Centrifuge 5415D; Eppendorf) and any residual plasma was further 
removed (Chiu et al. 2001). Blood cell samples collected were stored at -20°C until 
subsequent DNA extraction. 
3.1.3 Preparation of cell lines 
Trophoblast-derived choriocarcinoma cell lines JAR (Pattillo et al. 1972) and JEG3 
(Kohler and Bridson 1971) were purchased from the American Type Culture 
Collection (Manassas, VA). JAR was maintained in RPMI 1640 medium with 2 
mmol/L L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 
10 mmol/L HEPES, and 1.0 mmol/L sodium pyruvate (90%) and supplemented with 
fetal bovine serum (10%). JEG3 was maintained in Eagle's minimum essential 
medium with 2 mmol/L L-glutamine and Earle's balanced salt solution adjusted to 
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contain 1.5 g/L sodium bicarbonate, 0.1 mmol/L non-essential amino acids, and 1.0 
mmol/L sodium pyruvate (90%) and supplemented with fetal bovine serum (10%). 
The cells were incubated in a humidified atmosphere of 5% CO2 at 37°C. 
3.1.4 Treatment of JAR and JEG3 with 5-aza-2'-deoxycytidme (5-aza-CdR) and 
Trichostatin A (TSA) 
A methyltransferase inhibitor, 5-aza-CdR, was used to demethylate APC. After the 
seeding of JAR and JEG3, when the cells were observed to be at 20 to 30% 
confluence, 1 jumol/L or 3 |Limol/L 5-aza-CdR (Sigma-Aldrich, St. Louis, MO) was 
added to the medium. The medium and 5-aza-CdR were replaced every 24 hours. JAR 
was kept for 96 hours and JEG3 for 72 hours. To extend the effect of 5-aza-CdR, an 
inhibitor of histone deacetylases, TSA (Sigma-Aldrich, St. Louis, MO) was also added 
in some cases. For JAR incubated in 1 |imol/L 5-aza-CdR, either 0, 100, or 500 ng/ml 
TSA was added 24 hours before the cells were harvested. For JEG3 incubated in 1 
|dmol/L 5-aza-CdR, either 0, 50, or 100 ng/ml TSA was added 7 hours before the cells 
were harvested. DNA and RNA were isolated from the harvested cells using the 
QIAamp tissue kit (Qiagen, Hilden, Germany) and TRIZOL reagents (Invitrogen, 
Carlsbad, CA), respectively. 
3.2 Nucleic acid extraction 
3.2.1 DNA extraction from tissue samples 
DNA samples from tissue samples were extracted with the QIAamp DNA Mini Kit 
(Qiagen, Hilden, Germany) according to the tissue protocol provided by the 
manufacturer. The outline of the extraction procedure is illustrated in Figure 3.1. To 
extract DNA from tissue samples, 1 mg of tissue samples was cut into small pieces 
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and placed in a 2 RTIL microcentrifuge tube. 360 |LIL of Buffer A T L were added and 
mixed by inversion. After that, 40 [iL of Proteinase K were added to the tubes and 
mixed by vortexing. The mixture was incubated at 56�C overnight so that the tissue 
was completely lysed. After overnight incubation, 400 \iL of Buffer AL were added to 
the sample and mixed by vortexing. The mixture was further incubated at 70�C for 10 
min. 400 |LIL absolute ethanol were then added and mixed thoroughly to produce a 
homogeneous solution. The mixture was transferred into a QIAamp Spin Column and 
centrifuged at 16,000 g for 1 min. After discarding the filtrate, the extraction column 
was washed once with 500 |LIL of each of the two buffers, Buffer AWL and Buffer 
A W 2 , at 1 6 , 0 0 0 g for 1 min and 3 min, respectively. To elute D N A , 5 0 |LIL of sterile 
water were added to the extraction column, followed by centrifugation at 16,000 g for 
1 min. To achieve maximum yield, DNA was re-eluted in a new 1.5 mL 
microcentrifugation tube with another 50 |iL of sterile water at 16,000 g for 1 min. 
The extracted DNA was stored at -20�C until future use. 
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Figure 3.1. Outline of DNA extraction from tissue samples 
(Modified from QIAmp DNA Blood Mini Kit Handbook, Qiagen, 2003) 
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3.2.2 DNA extraction from blood cells 
DNA from peripheral blood cells was extracted according to the Nucleon™ extraction 
and purification protocols provided by the manufacturer. (GE Health 
Care-Biosciences, Little Chalfont, UK) It was recommended that 3 to 10 mL of blood 
samples be used for DNA extraction. To lyse the blood cells, 4 mL of Reagent A were 
added to every mL of blood sample in a screw-capped 15 mL polypropylene 
centrifuge tube and mixed gently for 4 min at room temperature. After incubation, the 
mixture was centrifuged at 1,300 g for 5 min. Supematants were discarded and 2 mL 
of Reagent B were added. The mixture was vortexed briefly to resuspend the pellet. 
To remove the proteins in the sample, 500 |liL of sodium perchlorate solution were 
added and mixed by inverting the tube. DNA extraction was performed by adding 2 
mL of chloroform to the sample. The sample was mixed by inverting the tube for at 
least 7 times until the separation of the mixture into 3 distinct layers. 300 |LIL of 
Nucleon resin were added to the sample without remixing the phases. The mixture 
was then centrifuged at 1,300 g for 3 min. After centrifugation, the colourless upper 
phase was transferred to a clean 15 mL polypropylene centrifuge tube without 
disturbing the Nucleon resin layer in order to minimize contamination from the 
protein interface. 2 volumes of cold absolute ethanol were added and mixed until a 
white precipitate appeared. The sample was centrifuged at 4,000 g for 5 min to pellet 
the DNA and the supernatant was discarded. To purify of the extracted DNA, 2 mL of 
cold 70% ethanol were added and mixed by inversion before re-centrifugation at 
4,000 g for 5 min. The supematants were discarded and the pellet was transferred to a 
clean 1.5 mL microcentrifuge tube and air-dried for 10 min at room temperature. 
Finally, DNA was eluted from the pellet using 150 )uL of water followed by 
incubation at 3TC for 2 hours before storing at -lO^'C until future use. 
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3.2.3 RNA extraction from cell lines 
Total RNA from cell lines was extracted with the TRIZOL Reagent (Invitrogen, 
Carlsbad, CA) followed by DNase I treatment (Invitrogen, Carlsbad, CA) according 
to the protocols provided by the manufacturer. Cells were lysed by adding 1 mL of 
TRIZOL Reagent and passing the cell lysate several times through a pipette. Insoluble 
materials were removed by centrifugation at 12,000 g for 10 minutes at 4°C. The 
supematants, which containsed RNA, were extracted and transferred to a fresh tube. 
The sample was incubated at room temperature for 5 minutes, to allow the complete 
dissociation of nucleoprotein complexes. 0.2 ml of chloroform was added and the 
sample tube was capped securely. The sample tube was shaken for 15 seconds and 
incubated at room temperature for 3 min. After incubation, the sample was 
centrifuged at 12,000 g for 15 min at 4°C. Following centrifugation, the aqueous 
phase was transferred to a fresh tube and 0.5 mL isopropyl alcohol was added in order 
to precipitate the RNA from the aqueous phase. The sample was incubated at room 
temperature for 10 min and centrifuged at 12,000 g for 10 minutes at 4°C. After 
centrifugation, the supernatant was removed and the RNA pellet was washed once 
with 75% ethanol. The sample was mixed by vortexing and centrifuged at 7,500 g for 
5 min at 4°C. Finally, the RNA pellet was air-dried and dissolved in 10 juL of 
RNase-free water by passing the solution a few times through a pipette tip, and 
incubating for 10 min at 55°C. To prevent DNA contamination, DNase I treatment 
was performed after RNA extraction. 1 jug of total RNA was mixed with 1 |LIL of 
DNAse I buffer, 1 |li1 Amplification Grade DNAse I and DEPC-treated water to 10 juL. 
The mixture was incubated for 15 min at room temperature. Finally, the reaction was 
inactivated by adding 1 |liL of 25 mM EDTA and heat for 10 min at 65°C before 
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storing at -70''C until future use. 
3.3 Methylation analysis 
3.3.1 Principles of bisulfite modification 
The detection of 5-methylcytosine using the sodium bisulfite reaction was first 
introduced in 1992 (Frommer et al. 1992). This approach relies on the ability that 
sodium bisulfite converts cytosine residues to uracil efficiently in single-stranded 
DNA, but 5-methylcytosine remains non-reactive. In this reaction, cytosine forms 
adducts across the 5-6 bond with the bisulfite ion to form a sulphonated cytosine 
derivative. The reaction is reversible and the extent of adduct formation is controlled 
by pH, bisulfite concentration and temperature. After hydrolytic deamination, the 
cytosine-bisulfite derivative gives a uracil-bisulfite derivative. This step is catalysed 
by basic substances, such as sulfite, bisulfite and acetate anions. Finally, the 
sulphonate group is removed by a subsequent alkali treatment to remove the bisulfite 
adduct and give uracil. Bisulfite reacts with cytosine either as the free base, the 
nucleoside (ribo- or deoxyribo-), the nucleotide or the oligonucleotide. The reaction is 
highly single strand specific. Although 5-methylcytosine can also react with bisulfite, 
the reaction is extremely slow. 
Several methods can be used to identify the differences in the sequence subsequent to 
bisulfite conversion. For example, it can be processed with cloning and sequencing, 
known as bisulfite sequencing (Frommer et al 1992). When interpreting the bisulfite 
sequencing data, one can identify the methylated cytosine as C while the 
unmethylated one as T. Another way to analyze the bisulfite converted sequence is to 
use methylation-specific PGR (MSP) (Herman et al. 1996). By this method, the 
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variants produced by bisulfite modification can be amplified by the specific primers 
targeting on the methylated sequence or the unmethylated one and differentiated by 
gel electrophoresis. 
3.3.2 Bisulfite Conversion 
Bisulfite modification on extracted DNA was performed using the EZ DNA 
Methylation Kit (Zymo Research, Orange, CA, USA). 1 |Lig of extracted DNA was 
used as a template for bisulfite conversion. 5 juL of M-Dilution Buffer were added and 
the sample volume was brought up to 50 jiiL with sterile water. The sample was mixed 
and incubated at 37"C for 15 min. Then, 100 juL of the prepared CT Conversion 
Reagent were added to the mixture which was further incubated at for 16 hours 
in the dark. After incubation, the mixture was placed on ice for 10 min. 400 juL of 
M-binding Buffer were added to each sample and the mixture was loaded onto a 
Zymo-Spin I Column. After centrifugation at 16,000 g for 30 s, the flow-through was 
discarded and the column was washed with 200 |iL of M-Wash Buffer and centrifuged 
at 16,000 g for 30 s. After washing the column, the sample was desulphonated by the 
addition of 200 i^L of M-Desulphonation Buffer and incubation at room temperature 
for 15 min. The column was centrifuged at 16,000 g for 30 s after the incubation. To 
purify the sample, the column was washed twice with 200 \iL of Wash Buffer and 
centrifugated at 16,000 g for 30 s and 1 min, respectively. Finally, the 
bisulfite-converted DNA were eluted with 25 |uL of sterile water and centrifuged at 
16,000 g for 1 min. 
3.3.3 Primer design for methylation-specific polymerase chain reaction 
Methylated and unmethylated molecules can be distinguished by single-nucleotide 
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changes after bisulfite modification. PCR primers are designed to amplify either the 
methylated or unmethylated molecules specifically. To achieve this, the primers were 
designed such that the degenerated nucleotide was located at the 3' positions of the 
primer, as previous studies have shown that the 3’ position of primers contribute most 
heavily to the primer's discriminatory power (Herman et al. 1996). Apart from their 
locations, the primers were also designed to produce amplicon sizes of no longer than 
approximately 400 bp in order to avoid the DNA degradation brought about by 
bisulfite conversion (Raizis et al. 1995). 
3.3.4 Methylation-specific polymerase chain reaction (MSP) 
The methylation status of human TSGs and non-TSGs was investigated by MSP 
(Herman et al 1996) after DNA bisulfite conversion. I targeted the 5' ends of the 
TSGs, which are the regions previously investigated by other research groups for 
differential methylation studies in varies cancer. The PCR primers specific to either 
the methylated or the unmethylated DNA sequences were designed according to the 
guidelines in Section 3.3.3 and the outline of procedure is shown in Figure 3.2. The 
primers were designed in the region where hypermethylation was previously reported 
in varies cancer. The primer sequences are listed in Table 4.1. 80 ng of 
bisulfite-converted DNA were used in each MSP. The Gene Amp PCR Core Reagent 
Kit (Applied Biosystems, Foster City, CA) was used for the PCR assays running in a 
reaction volume of 25 )liL consisting of Ix buffer II，200 |imol/L of each dNTPs, 200 
nmol/L of each primer, and 1 U of AmpliTaq Gold. The MgCl� concentrations used 
for each assay are listed in Table 4.2. CpGenome™ Universal Methylated DNA 
(Chemicon International, Temecula, CA) was used as a methylated control. 
CpGenome™ Universal Methylated DNA is human male genomic DNA treated with 
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Sssl methylase. No template controls were also amplified with each set of reactions. 
PCR products were analyzed by agarose gel electrophoresis and ethidium bromide 
staining. The thermal profiles used for the MSP assays are listed in Table 4.3. 
3.3.5 Primer design for bisulfite sequencing 
In order to prevent bias towards the amplification of either the methylated or 
unmethylated molecules, the primers were designed manually to prevent binding to 
any potentially methylated cytosine residues (Rein et al. 1998). When it is not 
possible due to the high density of CpG dinucleotides present in the target sequence, 
the nucleotide binding to the potentially methylated cytosine residue was degenerated 
to facilitate the amplification of both the methylated and unmethylated species. In 
contrast to MSP primer design, the primers were designed such that the degenerated 
nucleotide was not located at the 3’ positions of the primer. The primers were 
designed to produce amplicon sizes of no longer than 500 bp in order to avoid the 
DNA degradation brought about by bisulfite conversion (Raizis et al. 1995) and 
encompassing the regions investigated in the methylation-specific PCR. The locations 
of primers designed are illustrated in figure 3.2 by using APC as an example 
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Figure 3.2. Locations of primers designed ior APC methylation analysis 
The primers for methylation analysis in this thesis were designed at the 5' regions of 
the target genes. The locations of the primers used in different assays of APC are as 
indicated with different colour schemes. The GC rich region highlighted in blue 
indicates the CpG island and the bent arrow represents the transcriptional start. 
Key: 
^ ^ ^ ^ ^ Quantitative methylation-specific PCR assay 
<J=» Methylation-specific PCR assay 
Bisulfite sequencing assay 
33.6 Cloning and bisulfite genomic sequencing 
The bisulfite-converted DNA was amplified using non-methylation-specific primers 
designed according to the guidelines in Section 3.3.5 and the outline of procedure is 
shown in Figure 3.2. The reagents supplied in the TaqMan PCR Core Reagent Kit 
(Applied Biosystems, Foster City, CA) were used for these PCRs. The PCRs were set 
up in a final reaction volume of 25 ^L and consisted of primers, MgC12; IX Buffer II; 
200 ^M of each dNTP; 1.25 U of AmpliTaq Gold polymerase; 2 [iL of 
bisulfite-converted DNA were used as the template, corresponding to 80 ng of 
genomic template DNA, not considering the DNA loss during bisulfite treatment. The 
primer sequences are listed in Table 4.4. The amounts of primers and MgCl2 used in 
each PCR and the thermal profiles used for the bisulfite sequencing assays are detailed 
in Table 4.5. 
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Before cloning and sequencing, the PCR products were purified using the 
MicroSpinTM S-300 HR Columns (GE Health Care-Biosciences, Little Chalfont, UK) 
to remove the unincorporated primers. The column was first vortexed and centrifuged 
at 735 g for 1 min. After centrifugation, the flow-through was discarded and then the 
PCR products were added onto the column. The purified PCR products were obtained 
after centrifuging at 735 g for 2 min. 
The purified PCR products were TA-cloned into a plasmid vector (Frommer et al. 
1992) using the pGEM®-T Easy Vector System (Promega, Madison, WI). The ligation 
reaction was carried out at 16°C overnight by mixing the 2X Rapid Ligation Buffer, 
50 ng of pGEM-T Easy Vector, 3 Weiss units of T4 DNA Ligase and 3.5 ^L of PCR 
purified products in a 10 |iL reaction mixture. After the overnight ligation, the product 
was transformed into JM109 competent cells. 3 |LIL of ligation products were added to 
50 |LIL of JM109 competent cells, mixed gently and placed on ice for 20 min. After 
incubation, the cells were heat-shocked for 45 s in a water bath at exactly 42°C and 
returned to ice immediately for 2 min. 950 |iL of SOC medium were then added to the 
cells and incubated at 37°C with shaking at 150 rpm for 3 hours. Finally, the cells 
were centrifugated at 1,000 g for 10 min and resuspended in 100 |LIL of SOC medium. 
The cells were then plated on a LB/ampicillin/IPTG/X-Gal plate and incubated at 
37°C overnight. 
The successful recombinant clones could be identified by colour screening on 
indicator plates. Since successful cloning of an insert into the vector would disrupt the 
coding sequence of the P-galactosidase gene in the vector, the clone was unable to 
produce p-galactosidase and thus appeared white on a LB/ampicillinyiPTG/X-Gal 
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plate. Therefore, white clones indicated positive recombinant clones and were picked 
randomly for PGR amplification in order to confirm for the presence of inserts. 
Primers located at the SP6 and T7 promoters on the vector were used with the 
sequences of SP6 and T7 primers 5,-ATT TAG GTG AC A CTA TAG AA-3’ and 
5’-TAA TAG GAC TCA CTA TAG GG-3’，respectively. After confirming the 
presence of inserts inside the selected transformants, the inserts from positive 
recombinant clones were analyzed by cycle sequencing using the BigDye Terminator 
Cycle Sequencing vl . l kit (Applied Biosystems, Foster City, CA, USA). The product 
was purified by ethanol precipitation. 10 |LIL of Hi-Di formamide were added to each 
of the samples and run on a 3100 DNA Analyzer (Applied Biosystems, Foster City, 
CA, USA). The sequencing data were analyzed using the SeqScape Software (Ver. 2.5; 
Applied Biosystems, Foster City, CA, USA). The completeness of bisulfite 
conversion of the individual clones was first confirmed before scoring and the CpG 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Materials and methods 
3.4 Quantitative measurements of nucleic acids 
3.4.1 Principles of real-time quantitative PCR 
Real-time quantitative polymerase chain reaction, is a modification of polymerase 
chain reaction designed to quantify a specific part of nucleic acid during each 
amplification cycle of PCR (Holland et al. 1991). Two methods are commonly used 
for quantification: (1) Using fluorescent dyes that intercalate with double-strand DNA 
(2) Using modified DNA oligonucleotide probes that fluoresce when hybridized with 
a complementary DNA. In this thesis, the later method is used. The assay is based on 
the use of the 5' nuclease activity of DNA polymerase {Taq or xTth) to cleave a 
non-extendible hybridization probe during the extension phase of PCR (Holland et al 
1991). The approach uses dual-labelled fluorogenic hybridization probes consisting of 
a fluorescent reporter dye (FAM; 6 carboxyfluorescein) at the 5' end and a quencher 
dye (TAMRA; 6-carboxy-tetramethylrhodamine) at the 3' end. When the probe was 
intact, the close proximity of the reporter to the quencher prevents the reporter 
fluorescence by fluorescence resonance energy transfer (FRET) through space. If the 
target sequence is present, the probe hybridizes and is cleaved by the 5' nuclease 
activity of the Taq DNA polymerase as the upstream primer is extended. This 
cleavage of the probe separates the reporter dye from the quencher dye and increases 
the reporter dye signal. Since an additional amount of probe is cleaved in each PCR 
cycle, the number of isolated reporter dyes increases as the PCR progresses and the 
increase in the intensity of the fluorescence signal emitted is therefore proportional to 
the amount of amplicons produced (Heid et al 1996). The accumulated signal is 
detected by a sequence detector. Therefore, the reactions are monitored in real-time. 
The outline of real-time PCR principle is shown in Figure 3.3. 
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Real-time quantitative PCR possesses several advantages over conventional PCR. 
One of the main advantages is its high sensitivity and accurate quantification of trace 
amounts of template DNA. Therefore, it has been widely used for research 
applications. Numerous applications have been developed. For example, it can be 
combined with methylation-specific PCR to quantify the relative amount of 
methylation in a particular cell or tissue type (Lo et al. 1999c). It can also be 
combined with reverse transcription polymerase chain reaction to quantify messenger 
RNA (mRNA) so as to quantify the relative gene expression in a cell or tissue type 
(Myers and Gelfand 1991). 
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Figure 3.4. Principle of real-time PCR 
After annealing of the primers and probe, the proximity of the reporter dye to the 
quencher dye results in suppression of reporter fluorescence when the probe is intact. 
During polymerization, the probe fragments are displaced and cleaved by the 5' 
nuclease activity of the DNA polymerase. The cleavage causes separation of the 
reporter and quencher and the releases of fluorescence signal. 
(Adapted from the TaqMan EZ RT-PCR Kit Protocol, Applied Biosystems, 2002) 
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3.4.2 Real-time quantitative MSP 
In this thesis, real-time quantitative MSP assays for TSGs were developed to quantify 
the relative proportion of methylated and unmethylated molecules in different tissue 
types. It is basically a combination of MSP and real-time PCR. Briefly, it was 
performed using PCR primers and TaqMan probes specific for the methylated and 
unmethylated sequences, respectively (Lo et al. 1999c). The PCR was performed 
using a TaqMan PCR Core Reagent Kit (Applied Biosystems, Foster City, CA, USA) 
on an ABI 7300 sequence detection system (Applied Biosystems, Foster City, CA, 
USA). The primer, probe, and standard calibration sequences are listed in Table 5.1 
and reaction conditions are listed in Table 5.2 and 5.3. A calibration curve, prepared 
by serial dilutions of known concentrations of single-stranded synthetic DNA 
oligonucleotides (Proligo, Singapore) specific to the methylated and unmethylated 
amplicons, was run in parallel with each analysis. The methylation index (MI) of a 
sample was calculated by dividing the copies of methylated molecules by the total 
copies of methylated and unmethylated molecules. One genomic DNA universally 
methylated by Sssl methylase and one no template control were also included with 
each set of reactions. 
3.4.3 Real-time reverse transcriptase (RT)-PCR 
The gene expression of APC was evaluated by using one-step real-time RT-PCR (Ng 
et al. 2002). It was used to quantify the relative amount of mRNA of the gene in a 
sample by normalizing to the corresponding glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) mRNA concentration. This single-tube, single-enzyme 
quantitative system was performed by using the TaqMan® EZ RT-PCR Kit (Applied 
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Biosystems, Foster City, CA, USA). The reaction makes use of recombinant Thermus 
thermophilus {xTth) DNA polymerase, which functions both as a reverse transcriptase 
and a DNA polymerase (Myers and Gelfand 1991) and allows reverse transcription 
and PCR to take place in a “one-step” fashion without the subsequent addition of 
enzymes or buffers. In order to avoid genomic DNA amplification, the assay was 
designed with a pair of intron-spanning primers. The primer, probe, and standard 
calibration sequences are listed in Tables 7.1 and reaction conditions for the APC 
RT-PCR assay are listed in Table 7.2. The RT-PCR assays were performed in an ABI 
Prism 7300 (Applied Biosystems, Foster City, CA, USA). 
3.5 MALDI-TOF mass spectrometry (MS) 
3.5.1 Principle of homogeneous MassEXTEND assay and MALDI-TOF MS 
The homogeneous MassEXTEND (hME) assay is based upon the annealing of an 
extension primer adjacent to the polymorphic site of interest (Buetow et al 2001). 
The principle is outlined in Figure 3.4. Firstly, PCR products are generated and 
sequently treated with shrimp alkaline phosphatase. Primer extension reaction is then 
performed with the addition of Thermosequenase (Sequenom, San Diego, CA) and a 
mixture of deoxyribonucleotides (dNTP) and dideoxynucleotides (ddNTP). The 
reaction allows the extension of primer through the polymorphic site and generates a 
unique mass product. The differences in mass products are brought about by 
incorporation of different combinations of dNTP on the polymorphic site before 
terminated by the incorporation of a ddNTP. The resultant mass of the primer 
extension product is then analyzed by the matrix-assisted laser desorption 
ionization/time-of-flight mass spectrometry (MALDI-TOF MS) and used to determine 
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the sequence of the nucleotides at the polymorphic site according to their mass 
differences. MALDI-TOF MS is used for size determination of the extended products 
because of its speed and accuracy. It is capable of resolving DNA sequences that 
differ by a single nucleotide. 
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Figure 3.5. Principle of homogeneous MassEXTEND assay and MALDI-TOF 
MS 
A DNA sequence containing a C/T SNP is amplified by PCR as shown on the top of 
the figure. After SAP treatment of the PCR products, the extension primer, enzyme 
and a combination of dTTP and ddNTPs mixture are added to the PCR products. 
The PCR products are extended by either one or two nucleotides depending on the 
allele. The extended PCR products are then detected by the MALDI-TOF MS and 
resolved by their mass differences. The results are illustrated in the mass spectra. 
(Modified from the Multiplexing hME Application Note, Sequenom, 2004) 
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3.5.2 Methylation-sensitive restriction enzyme digestion and homogeneous 
MassEXTEND assay for APC and H19 
Polymerase chain reactions were designed to amplify a segment of APC and H19 
surrounding the SNPs rs2019720 and rs2107425, respectively. One BstUL cutting site 
was present within each of the amplicons. 20ng of extracted genomic DNA was 
subjected to endonuclease digestion with a methylation-sensitive restriction enzyme, 
万对UI (New England Biolabs, Ipswich, MA) by incubation at 60°C for 16 hours using 
IX NE Buffer 2 and lOOU 5对UI in a total volume of 20 [iL. The digested DNA was 
then subjected to PCR amplification in two separate PCR assays, corresponding to 
each of the APC and H19 gene. The primers for both the APC and HI9 assays are 
shown in Table 6.1. The two PCR assays were conducted in a total reaction volume of 
25 IliL consisting of the following components from the TaqMan PCR Core Reagent 
Kit (Applied Biosystems, Foster City, CA, USA): IX Buffer II; 2 mM MgCh； 200 
|LIM of each dNTP; 200 NM of each of the forward and reverse primers; 1.25 U of 
AmpliTaq Gold polymerase; 5 |uL of 5^^UI-digested DNA was used as template. The 
thermal profiles of the two PCR assays were identical and consisted of an initial 
denaturation step of 95�C for 10 min followed by 40 cycles of 95�C for 30 s, 6 0 � C for 
30 s, 72°C for 1 min 30 s, and a final incubation at 72°C for 5 min. Subsequent to 
PCR amplification of the two genes, the PCR products were subjected to 
dephosphorylation of any unincorporated nucleotides from the previous PCR in order 
to prevent their incorporation and interference with the subsequent primer extension 
assay. This dephosphorylation step was conducted by adding a mixture, which was 
comprised of 0.85X hME buffer and 0.60 U of Arctic shrimp alkaline phosphatase 
(SAP), to each PCR product. After the addition of these components, the mixture was 
incubated at 37°C for 40 min followed by 85°C for 5 min. 
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Subsequent to SAP treatment, the primer extension reactions were preformed by 
adding a cocktail of termination mixture containing 2.25 m M of each dNTP/ddNTP, 
400 n M extension primer and 1.152 U of thermosequenase to every 10 juL of 
dephosphorylated PCR product in a final reaction volume of 14 |LIL. The primer 
extension reaction was performed with the extension primer APC-EF 5，-AAC TAA 
CAA A G A CAC TGG TA-3' for the APC assay and H19-EF 5'-GGG AAT AGG ACA 
CTC AT-3' for the H19 assay. The components of the termination mixture used in the 
primer extension reactions for the APC were dGTP, ddATP, ddCTP and ddTTP; for 
H19 were dTTP, ddATP, ddCTP and ddGTP. The thermal profile of the two primer 
extension reactions was identical and comprised of 94°C for 2 min followed by 75 
cycles of 94。C for 5 s, 52°C for 5 s, 72°C for 5 s. 
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CHAPTER 4: Screening on TSGs and non TSGs 
4.1 Introduction 
The human placenta undergoes a complex process of reorganization during pregnancy 
for successful placentation so that it can be functionally synchronized with the 
development o f embryonic fetal and maternal compartments (Ohlsson et al 1993). 
Placentation involves a series of orchestrated events including cytotrophoblast 
differentiation, uterine invasion and remodelling of the uterine vasculature (Janatpour 
et al. 1999). Although the placenta is a normal tissue, its constituent cells, the 
trophoblastic cells, share many similarities with malignant cells. Analogies have been 
drawn between trophoblastic cells and malignant cells in terms of their biological 
behaviour, such as high proliferation, lack o f cell-contact inhibition, migratory 
abilities and invasive properties (Bischof et al. 2001), as well as their gene expression 
profiles (Janneau et al. 2002), for example the expression of growth factors, 
angiogeneic factors (Zhou et al 2003) and certain proto-oncogenes (Ohlsson et al. 
1989). These have led to the definition of the trophoblast as a pseudomalignant tissue 
(Strickland and Richards 1992). However, few analogies have been drawn on the 
epigenetic level. 
D N A methylation is one of the best studied epigenetic phenomena in human cells. In 
tumour cells, tumour suppressor genes (TSGs) silencing by gene promoter 
hypermethylation is a well recognized mechanism associated with the pathogenesis of 
malignancies (Herman and Baylin 2003). In trophoblast cells, the epigenetic 
phenomena such as genomic imprinting (Bartolomei and Tilghman 1997) and X 
chromosome inactivation (Migeon et al. 2005, Reik and Ferguson-Smith 2005), 
which often involve DNA methylation have been well studied. However, few studies 
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have systematically investigated the methylation status o f TSGs in the human 
placenta and compared it between malignant cells and trophoblastic cells. 
Fol lowing the discovery o f RASSFIA by my supervisor's group, I hypothesized that 
hypermethylation o f other tumour suppressor genes can be found in the placenta. The 
aim o f this chapter is to investigate the methylation status of TSGs to see i f there is 
any promoter hypermethylation of TSGs in the placenta. I started by studying the 
methylation status o f forty-six TSGs in human placental tissues. Further, to study 
whether promoter hypermethylation is unique for TSGs, I investigated the 
methylation status o f fifteen genes for which no tumour suppressing function has been 
reported. 
4.2 Materials and methods 
4.2.1 Sample collection 
Pregnant women with uncomplicated pregnancies who attended the Department o f 
Obstetrics and Gynaecology at the Prince of Wales Hospital, Hong Kong were 
recruited wi th informed consent. The study and the collection of human clinical 
samples were approved by the Joint CUHK-NTEC Clinical Research Ethics 
Committee. First-trimester and third-trimester placental tissues were collected and 
processed as described in 3.1.1. 
4.2.2 Sample processing and DNA extraction 
Blood sample processing is described in 3.1.2. DNA extraction procedures of blood 
samples and placental tissues are described in 3.2.1 and 3.2.2, respectively. 
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4.2.3 Experimental Design 
Methylation-specific polymerase chain reaction (MSP) was used for screening o f 
hypermethylated TSGs in the placenta by comparing their methylation status in the 
placental tissue samples with that in the blood cells. The screening process was 
divided into two sets o f MSP analysis. 
In the first set o f analysis, six TSGs were investigated with five pairs o f placental 
tissues and their corresponding maternal blood cells. PCR primers in this group were 
designed to amplify both methylated D N A sequences and unmethylated D N A 
sequences. Both first-trimester and third-trimester placental tissues and their 
corresponding maternal blood cells were investigated. 
In the second set of analysis, the remaining forty TSGs were investigated with two 
pairs of placental tissues and their corresponding maternal blood cells. PCR primers 
in this group were designed to amplify the methylated DNA sequences and only 
third-trimester placental tissues and their corresponding maternal blood cells were 
investigated. 
PCR products obtained from MSP were visualized by gel electrophoresis. The 
intensity of the PCR product bands visualized on the gel was compared. For any 
hypermethylated genes, the intensity of the PCR product bands in the placental tissue 
samples should be higher than that in the corresponding blood cells. For the candidate 
hypermethylated TSGs identified in the second set of screening, MSP would be 
further performed on five pairs of placental tissue samples and their corresponding 
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blood cells in order to confirm their hypermethylation consistency in different 
individuals. 
Finally, all the candidate genes were validated by bisulfite genomic sequencing with 
five pairs o f placental tissue samples and their corresponding blood cells in the first 
trimester as well as in the third trimester. 
Methylation-specific polymerase chain reaction (MSP) 
The methylation status of 46 TSGs and 15 non-TSGs was investigated by MSP after 
bisulfite conversion. Bisulfite conversion of the extracted DNA is described in 3.3.2 
and primer design for the TSGs was described in 3.3.3. Procedures for the MSP assay 
are described in 3.3.4. The primer sequences are listed in Table 4.1. 80 ng of 
bisulfite-converted D N A were used in each MSP. The MgCl〗 concentrations used for 
each assay are listed in Table 4.2. The thermal profiles used for the 
methylation-specific PCR assays are listed in Table 4.3. 
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Table 4.1: Primer sequences for methylation-specific peR 
Oligo Sequence (5' to 3') , Product length (bp) 
TSGs 
APC-MF TATTGCGGAGTGCGGGTC 141 
APC-MR CAATACAACCACATATCGATCACGTACG 
APC-UF TGTGTTTTATTGTGGAGTGTGGGTT 151 
APC-UR CACCAATACAACCACATATCAATCACATACA 
FHIT-MF GCGGGTTTGGGTTTTTACGC 122 
FHIT-MR CCACCCTAAAACCCTCGTAAAACG 
FHIT-UF GGGTGTGGGTTTGGGTTTTTATGT 128 
FHIT-UR CCCCACCCTAAAACCCTCATAAAACA 
GJB2-MF GGGGGTTCGCGGA TTC 215 
GJB2-MR CTAAACCGAACGCCGCCG 
'GJB2-UF GGTTGGGGGTTTGTGGATTT 228 
GJB2-UR AAACAAATCCTAAACCAAACACCACCA 
PTEN-MF GGTTTCGGAGGTCGTCGGC 158 
PTEN-MR CCGCAACCGAATAATAACTACTACGACG 
PTEN-UF GTTTGGGTTTTGGAGGTTGTTGGT 166 
PTEN-UR AAACCACAACCAAATAATAACTACTACAACA 
SFN-MF GATATGGTAGTTTTTATGAAAGGCGTC 197 
SFN-MR TCCCGATACTCACGCACCTCG 
SFN-UF GAGGATATGGTAGTTTTTATGAAAGGTGTT 206 
SFN-UR ACCTTCTCCCAATACTCACACACCTCA 
TP53-MF TTTGTTTTGTTTTTTTCGGTAGGC 215 
TP53-MR ~~~~~~~~~~~~~~~~~~~ ~~AA~~~AAAAIAI~~~~~ 
TP53-UF ATTTTATTTGTTTTGTTTTTTTTGGTAGGT 224 
TP53-UR ACCCAAACACAAAATATCCCCA 
ATM-MF TCGAGTCGAAGGGCGAGTC 237 
ATM-MR CAACTACCTACTCCCGCTTCCG 
CASP8-MF GGTTAGGGGATTCGGAGATTGC 331 
CASP8-MR AAAAAAACCGTATATCTACATTCGAAACG 
CAV1-MF AAAAGTTAAAGATTTTTATTTTTTATTTCGAAGC 145 
CAV1-MR CTATAATATACTTTTAATAACACTCGTTTACATCTAATCG 
CDH4-MF TGCGTTTTTAAGGTTCGCGTC 184 
CDH4-MR AAACCAAACCAAATCCGACCG 
CDH13-MF GCGGGGTTCGTTTTTCGC 241 
CDH13-MR GACGTTTTCATTCATACACGCG 
CHFR-MF AGTTATTTTCGTGATTCGTAGGCGAC 146 
CHFR-MR CCGCGATTAACTAACGACGACG 
DAB2IP-MF GTAAGGGTGCGGGTTTCGC 230 
DAB2IP-MR GAACTCACCTCTCATTATCCGCG 
DBCCR1-MF TTGTAAATTGATTTGGCGCGC 257 
DBCCR1-MR CGCATTCCGAACACGACG 
DCC-MF GTGTGAGTGTTGTCGTTGTTCGC 151 
DCC-MR ACTTACCGATTACTTAAAAATGCGCG 
DLC1-MF GGGAGGGTTCGGTTGGC 129 
53 
Screening on TSGs and non-TSGs 
DLC1-MR I A C G A A A A A T C C G T A A A C C G A C G 
ID4-MF GGTTTTATAAATATAGTTGCGCGGC — 134 
ID4-MR AAACTCCGACTAAACCCGATCG — 
IGSF4-MF TGTAAGGTGAGTGACGGAAATTTGTAAC 159 
IGSF4-MR TCAAAAAAAAAATATTCTCCCGAACG — 
KLF4-MF GGTGTTTTAGTTGTTTCGGGTTGTC — 
KLF4-MR AAAATCAAAAACGACTTTCGACCG 
LOX-MF TGAATAAATAGTTGAGGGGCGGTC _ ?48 
LOX-MR TCCTAAAAAACAACGAAAAACGACG 
MCC-MF GTATCGTAGGAGTGGCGAGGC 一 I M 
MCC-MR CAAAAAACTCGATAACGCGACG 
MLH1-MF GACGTAGACGTTTTATTAGGGTCGC — ^ 
MLH1-MR CGAAACTCTAATTTTCCGACCCG “ 
MSH2-MF TCGTGGTCGGACGTCGTTC — 
MSH2-MR ACGAAACCGACCTCGACCG 
MY〇18B-MF GGTTAACGGTTATTTCGGGTTGTC 5T5 
MY018B-MR CCGAACCGAAAAAACAAAAACG 
PRDM2-MF GGTTATTGGGCGACGGC 165 
PRDM2-MR TCGCCGACCCCGACG 
PTPN6-MF AAGGTATGTGAACGTTATTATAGTATAGCGTTC ~ ~ m 
PTPN6-MR AAACCCAAATAATACTTCACGCATACG 
PYCARD-MF GTAGCGGGGTGAGCGGC 189 
PYCARD-MR AACGTCCATAAACAACAACGCG 
RASSF2-MF CGGGGGTCGTTGGTTTTTC 一 ?27 
RASSF2-MR CACGACACCTACCTCGCTCG 
RASSF5-MF GGTACGGATTTTATTTTTTTCGGTTC W 
RASSF5-MR TTAACAACGACGACTTTAACGACTACG 
RBP-MF GCGTTGGGAATTTAGTTGTCGTC 一 ^ 
RBP-MR GCAACGAACAACGCTTACCG 
RUNX1-MF GGTTTGTGATTGGTCGTCGGTC 206 
RUNX1-MR CCCGAAAAAAAATACCTAACGACG 
SCGB3A1-MF TTTAGTTTTGTAGGGGGGCGC — 
SCGB3A1 -MR ACCAACTTCCTACTACGACCGACG 
SEMA3B-MF TGTGGTTAGGCGGGGTATTTTC ^ 
SEMA3B-MR CCAAACCCGAAATCACGACG 
SEMA3F-MF GATTTTTTATTTACGGGGCGGCG ^ 
SEMA3F-MR GAAAAAAAACGCTACCTCGAACG 
SFRP1-MF TTTTCGGAGTTAGTGTCGCGC m 
SFRP1-MR CAATCCCCAACGTTACCCG “ 
SLIT2-MF CGTGAGTGAGTAGAGTTTAGAGTCGTGC ^ 
SLIT2-MR - AATAAACTCCGAAAACTAAAAAACGCG 
SMAD4-MF GTTATTCGGAGCGGGAGGC 
SMAD4-MR CGTTACCGCAACGACGACG 
SOCS1-MF GTTTCGGGATTTACGAGTATTCGC 179 
S0CS1-MR CGACACAACTCCTACAACGACCG 
SYK-MF CGATTTCGCGGGTTTCGTTC ^ 
SYK-MR GAAAACGAACGCAACGCG 一 
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THY1 -MF GTAATTTGTTATTTTTATATTAATGCGGGATC 185 
THY1-MR CCTCCGATTACTACACCCAACTCG 
TMEFF2-MF CGTCGTCGTTTTTGTTGTCGTC 236 
TMEFF2-MR AAAACAACGAACTTCACCGAACG 
TNFRSF10A-MF TCGAATTTCGGGAGCGTAGC 164 
TNFRSF10A-MR CGCCCTACCCGAACCCG 
TUSC2-MF TGTTGGGATTTGGGATTTCGTAAC 183 
TUSC2-MR GCTAATCGCAAATACCGCCG 
WIT-1-MF AA TTTCGGGGTGTTTTTTCGTTC 172 
WIT-1-MR CGAACATATAAATCCGTTAAAATCGTACG 
WWOX-MF AGTGGATTCGGTAGCGGGC 228 
WWOX-MR CCGCGCAAATAACGTCCG 
ZMYND10-MF ATTCGTGGGTTATAGTTCGAGAAAGC 167 
ZMYND10-MR AACCATAAAAACGAATTAACCGCG 
Non TSGs 
ARHGDIA-MF AGGGTAGCGTATTGTATTTGCGC 316 
ARHGDIA-MR AAACTTCCGCTCACTCGAACG 
CKLF-MF TCGTTATTAACGTTAGGTTAGAATACGGC 221 
CKLF-MR ACTTCCCGCTCTCTTACGCG 
GABRB2-MF GGT AGCGGGAACGTTTATTTTTTTC 276 
GABRB2-MR TCCTAAAACTCAAACCGCCTCG I 
GAPD-MF GTGTTTAGTTGAATTAGGCGGTTGC 185 I 
GAPD-MR TCAATTTATAAAAACCGAAAACGCG 
HCK-MF GGAGGTTATGATTTTCGGGGAGTC 149 
HCK-MR ACCAAAAACGTAATAACGCCCG 
HSPCB-MF I I AT AAGT AAA TGTGTGGGCGGATTC 233 
HSPCB-MR AACAATCCCAACACTACGCCG 
NDUFB7-MF TTGTTTCGTTTTCGTTTGTTCGC 241 
NDUFB7-MR TCGAACTCCACCGAAACATCG 
PROK2-MF GCGGGGTT AGTTTTT A T AACGGTTC 135 
PROK2-MR GCCCTCGAAACTAAACGACCG 
RGS2-MF TTCGGTAGTAGTCGTGATTGTCGTC 166 
RGS2-MR CCCGACTATTTACGACTAAACGTACG 
RPL 19-MF TGAAAGAATCGGATAGGAATACGGAC 132 
RPL 19-MR CCCTCACCTCATAACTACGACCG 
CIITA-MF GGTGGTAGATATTGGTAGTTGGTATTAGTGC 242 
CIITA-MR TCTCCCTACAAAATAACCCCAAACG 
ESR1-MF GAGTTTAACGTCGCGGTCGTC 188 
ESR1-MR AACTACAAAAAAAACGACAACTACGACG 
FOXF1A-MF CGTTCGGGAGAAGTGGTCGTC 212 
FOXF1A-MR ACGATAACTACTACTTCTCGAACGCCG 
MYOD1-MF GACGTAGATTTGACGGTTTTCGAC 217 
MYOD1-MR GCACATACTCGTCCTCACGTACG 
TERT-MF GCGGGTATAGACGTTTAGGATCGC 259 
TERT-MR GAAACCAAAACTTCCCACGTACG 
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Notes on oligo suffix, sequence prefix and suffix: 
MF Forward primer, methylated target 
MR Reverse primer, methylated target 
MP TaqMan probe, methylated target 
MS Calibration standard, methylated target 
UF Forward primer, unmethylated target 
UR Reverse primer, unmethylated target 
UP TaqMan probe, unmethylated target 
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Bisulfite genomic sequencing 
D N A extracted from the first-trimester placentas with their corresponding maternal 
blood cells and the third-trimester placenta samples with their corresponding maternal 
blood cells were subjected to bisulfite genomic sequencing. Bisulfite modification on 
extracted D N A was performed by using the EZ D N A Methylation Ki t (Zymo 
Research, Orange, CA) as described in 3.3.2. 1 jug of each extracted D N A sample was 
incubated at 50°C for 16 hours after addition of the CT conversion reagent. Cloning 
and bisulfite genomic sequencing on the bisulfite converted D N A was performed as 
described in 3.3.6. The PCR primers are listed in Table 4.4 and the PCR conditions of 
TSGs sequencing reactions are summarized in Table 4.5 and 4.6. 
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Table 4.4 Primer sequences for bisulfite sequencing (human) 
















Notes on oligo suffix, sequence prefix and suffix: 
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4.3 Results 
4.3.1 Identification of hypermethylated TSGs by methylation-specific PCR 
screening 
I examined the methylation status of 46 TSGs and 15 non-TSGs in human placental 
tissues by methylation MSP. Hypermethylation was observed in eight of the studied 
loci, namely APC，CASP8’ DAB2IP, PTPN6, PYCARD, SCGB3A1, TMEFF2 and 
THYl. However, only methylation of 6 out of 8 loci (APC, CASP8, DAB2IP，PTPN6, 
SCGB3A1 and THYl) were observed in all third trimester (n = 5) placentas examined 
but not in the blood samples collected from pregnant women. The result of MSP is 
shown in Figure 4.1, 4.2, 4.3 and 4.4. Seven of the studied loci {WWOX, MLHl, 
CRBPl, SFRP, TUSC2, ATM and DBCCRl) were observed to be hypomethylated in 
the placenta, i.e. methylated in placenta but unmethylated in the corresponding 
maternal blood cells. Eight of the studied loci (SFN, MY018D, ID4, SEMA3B, 
SEMA3F, CDH13, CAVl and SLIT2) were observed to be methylated in both 
placental samples and the maternal blood cells. The remaining loci were observed to 
be unmethylated in both placental samples and maternal blood cells. None of the non 
-TSGs studied were found to be hypermethylated in the placenta. Representable MSP 
results are shown in Figure 4.5. 
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First trimester 
Figure 4_1A 。, 
Placenta Maternal buffy coat 
DNA ” z 
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Figure 4.1 B Third trimester 
Placenta Maternal buffy coat 
DNA 眺 2 z 
_ j v | UMUMUMUMU MUMUMUMUMU MU^ ^ 
^^B rP53 
^ - - - - 、 “ ™ f e ^ 丄 ‘ … 她 盖 
PTE/V 
Figure 4.1. First set of MSP analysis on TSG 
The first set of MSP analysis on six TSGs in first (A) and third (B) trimester human 
placental tissues and their corresponding maternal blood cells. Sss\ methylase-treated 
DNA was used as a positive control for the methylated sequence. Genes are identified 
by the official symbols according to the Human Genome Organization (HUGO) gene 
nomenclature. M, methylated; U, unmethylated; NTC, no template control. 
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Figure 4.2A Genes hypermethylated in placenta 
CASPS加 0AB2/P SCGB3A1 (HIN^1) 
Pi-N PLN PLN M ^ ™ PLN MBC B w 
‘ • ： 丄 . 】 
THY1 PYCARD TMEFF2 
PLN MBC "ir^ .Tc PLN MBC PLN MBC S%TC 
Figure 4.2B Genes hypomethylated in placenta 
MLH1 WWOX CRBP1 TUSC2 
PLN MBC i J V P_LN MBC PkN MBC 型 MBC 
驟 糧 ^ ^ 鐵 變 零 耀 輕 零 ^ ^ ^ ^ ^ 》 氣 驟 ^ ^ ^ ^ ^ ^ ^ ^ ^ 芬 邏 
； ‘ ！ I 一 … L . i ： 
SFRP ATM DBCCR1 
PyN_MBcHr.-c PJM MBC^-,,^ PLN MBCjrVr, 
Figure 4.2C Genes methylated in placenta and 
blood cells 
f[)4 MY018D SEMA3B SEMA3F 
陛 醒 i i w PLN M^Bw PLN mcBw PLN 醒祭W 
CD_ CAV1 SUT2 
PLN MBC PLN MBC iff PLN MBC 
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Figure 4.2D Genes unmethylated in placenta 
and blood cells 
CDH4 KLF4 LOX MCC 
PLN MBC^h.c PLN mC]B\rc PJ.N mcBw EKN NTC 
CHFR ocC DLC1 RASSF2 
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；.. - - is；. “ ； J 
TNFRSF10A RASSF5 S0CS1 SYK 
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RUNX1 IGSF4 WfT-1 MSH2 
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PRDM2 SMAD4 ZMYND10 
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Ij^^riM 
Figure 4.2. Second set of MSP analysis on TSGs 
The second set of MSP analysis on 40 TSGs in third trimester human placental tissues 
and their corresponding maternal blood cells. Genes were grouped according their 
comparative intensity of PCR products in the placenta and blood cells. 7 genes were 
hypermethylated in the placenta (A), 7 genes were unmethylated in the placenta (B), 7 
genes were methylated both the placenta and blood cells (C), 19 genes were 
unmethylated in both in the placenta and blood cells (D). methylase-treated D N A 
was used as a positive control for the methylated sequence. Genes are identified by 
the official symbols according to the HUGO gene nomenclature. PLN, placenta; 
MBC, maternal blood cells; NTC, no template control. 
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MSP on hypermethylated TSGs with five pairs of 
placenta and maternal blood cells 
Placenta Maternal blood cells 《=<» 
ONA NTC 
CASP8 ( > 
DA82识 
PTPN6 I « * 、 条 ’ ； ‘ . r / 鐘 
SCGB3A1 I ： ^ , , - ‘ 1 . , ^ J 
THY1 I f I t f ^ 、-:、、'：、々於’‘ 
TMEFF2 
Figure 4.3. Confirmation of hypermethylated TSGs with five cases 
Confirming the 7 hypermethylated TSGs with MSP on five pairs of third-trimester 
placental tissue samples and their corresponding maternal blood cells. 
methylase-treated DNA was used as a positive control for the methylated sequence. 
Genes are identified by the official symbols according to the HUGO gene 
nomenclature. PLN, placenta; MBC, maternal blood cells; NTC, no template control. 
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MSP analysis o f non-TSGs 
ARHGDIA NDUFB7 GABRB2 GAPD RPL19 
Sssi Snai ；fiis 丨 1 ^T^ssi MBC ELM 二〜TC MBC Bil^ r^NTc MiC PLN Mf ntc MBC PLN I^f f ' L N MBC 7,T\,rr 
HSPCB CKLF2 PR0K2 RGS2 HCK 
MiC ElN^ -'nic MBC PUISKtc MOC PLN ^ -^tc MBC ELH S^ntc f I PL‘丨? 
___________ li^^^^M^s 
^ ^ ^ ^ ^ ^ iiiiiilii^Mii 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ m^mwrnmrnMrn^m^^^^ MMMMM&i^^ii^mm^^mMM W^^^i^^mmsm!^^^^^ 
a m ESRi F0XF1A MYOD1 TERT 
•srwi sxsi SsAt Ssjii Zssi 
FLN TC PUi rv干PLN MBC^Turt PLN tv1BC二Inc fUi MBcH^ m^tc 
• 【 〜 . 、 丨 陶 [ 二 
Figure 4.4. MSP screening result for non-TSGs 
MSP analysis of fifteen non-TSGs in third-trimester human placental tissues and their 
corresponding maternal blood cells. Sssl methylase-treated DNA was used as a 
positive control for the methylated sequence. Genes are identified by the official 
symbols according to the HUGO gene nomenclature. PLN, placenta; MBC, maternal 
blood cells; NTC, no template control. 
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4.3.2 Validation of hypermethylated TSGs by bisulfite sequencing 
I further confirmed the methylation status of the hypermethylated and hypomethylated 
loci by bisulfite sequencing. For the six hypermethylated loci, APC, CASP8, DAB2IP, 
PTPN6 and SCGB3A1’ bisulfite sequencing was performed on first- (n = 5) and 
third-trimester (n = 5) placentas. However, no differential methylation was observed 
in the THYl loci (Appendix III), while hypermethylation of the other five loci was 
observed in all the placental tissues examined with maternal blood cells being 
unmethylated. The data of one representative first-trimester case are shown in Figure 
3.5 and those from one representative third-trimester case are shown in Figure 3.6. 
The data from all cases are shown in Appendix I. 
The methylated site frequency (MSF) (number of methylated sites / all cloned CpG 
sites) in the first-trimester ranged from 0.180 to 0.308 for APC, 0.275 to 0.467 for the 
CASP8 exon 1, 0.136 to 0.498 for the DAB2IP promoter, 0.170 to 0.563 for the 
SCGB3A1 promoter and 0.758 to 0.838 for the PTPN6 promoter. The MSFs for all 
maternal blood cell samples collected in the first trimester were less than 0.081. For 
the third-trimester placental samples, the MSF ranged from 0.172 to 0.476 for APC, 
0.188 to 0.591 for the CASP8 exon 1, 0.136 to 0.498 for the DAB2IP promoter, 0.321 
to 0.570 for the SCGB3AI promoter, and 0.832 to 0.987 for the PTPN6 promoter. The 
MSFs for all maternal blood cell samples collected in the third trimester were less 
than 0.059. In all cases, the MSF of the placental tissue was higher than that of the 
corresponding blood cell sample. 
For the candidate hypomethylated loci, one locus, TUSC2, was picked to confirm its 
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methylation status by bisulfite sequencing with one pair of placental and maternal 
blood sample. However, no methylation was observed in both placenta and maternal 
blood cells examined (Appendix III). 
SEMA3B was picked for bisulfite sequencing and confirmed that it was methylated 
both in the placenta and blood cells (Appendix III). 
For the non-TSGs, CIITA was reported to be hypermethylated in placental cell lines 
(Morris et al. 2002). However, no hypermethylation of placenta could be observed 
from the bisulfite sequencing results (Appendix III). 
70 
Screening on TSGs and non-TSGs 
Figure 4_5A 
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Figure 4.5E 'sCGB3A1 promoter 
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Figure 4.5. Bisulfite sequencing of hypermethylated TSGs in first-trimester 
samples 
Cloning and bisulfite sequencing of the APC promoter (A), CASP8 (B), DAB2IP (C), 
PTPN6 (D), SCGB3AI (E) in first-trimester placental tissues and the corresponding 
maternal blood cells. Results for one placental tissue sample and its corresponding 
blood cell sample are shown. Five cases each from the first trimester of pregnancy 
were studied, and results are shown in Appendix I. Circles along one column 
represent one CpG site (f i l led circles, methylated; open circles, unmethylated). Each 
row represents one clone. 
The position of the analyzed CpG sites are assigned according to the APC {Homo 
sapiens) GenBank Accession NM—000038, CASP8 {Homo sapiens) GenBank 
Accession NM—033355, DAB2IP {Homo sapiens) GenBank Accession NM—138709, 
PTPN6 {Homo sapiens) GenBank Accession NM—080549 and SCGB3A1 (Homo 
sapiens) GenBank Accession NM—052863 with the start codon of their protein coding 
sequence as position +1. 
The first U P C CpG site (-17372) corresponds to chr5:112101115. The first ^CASP8 
CpG site (-8166) corresponds to chr2:201831289. The first 了DAB2IP CpG site 
(-57635) corresponds to chr9:123501488. While the first ^PTPN6 CpG site (-564) 
corresponds to chr 12:6930373 and that for ^SCGBSAl CpG site (-367) corresponds to 
chr5:179951435 of the human genome in the UCSC Genome Browser (March 2006 
assembly, hgl8) . 
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Figure 4.6A 
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Figure 4.6E promoter 
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Figure 4.6. Bisulfite sequencing of hypermethylated TSGs in third-trimester 
samples 
Cloning and bisulfite sequencing of the APC promoter (A), CASP8 (B), DAB2IP (C), 
PTPN6 (D), SCGB3A1 (E) in third-trimester placental tissues and the corresponding 
maternal blood cells. Results for one placental tissue sample and its corresponding 
blood cell sample are shown. Five cases each from the third trimester of pregnancy 
were studied, and results are shown in Appendix I. Circles along one column 
represent one CpG site (filled circles, methylated; open circles, unmethylated). Each 
row represents one clone. The position of analyzed CpG sites are assigned according 
to the APC {Homo sapiens) GenBank Accession NM—000038, CASP8 {Homo 
sapiens) GenBank Accession NM—033355, DAB2IP {Homo sapiens) GenBank 
Accession NM—138709, PTPN6 {Homo sapiens) GenBank Accession NM_080549 
and SCGB3A1 {Homo sapiens) GenBank Accession NM—052863 with the start codon 
of their protein coding sequence as position +1. 
The first ^APC CpG site (-17372) corresponds to chr5:112101115. The first ^CASP8 
CpG site (-8166) corresponds to chr2:201831289. The first ^DAB2IP CpG site 
(-57635) corresponds to chr9:123501488. While the first ^PTPN6 CpG site (-564) 
corresponds to chr 12:6930373 and that for ^SCGBSAl CpG site (-367) corresponds to 
chr5:179951435 of the human genome in the UCSC Genome Browser (March 2006 
assembly, hgl8). 
76 
Screening on TSGs and non-TSGs 
4.4 Discussion 
In this chapter, I have investigated the methylation status of forty-six known tumour 
suppressor genes. Five TSGs, APC, CASP8, DAB2IP, SCGB3A1 and PTPN6, were 
found to be hypermethylated only in the placenta but unmethylated in the maternal 
blood cells. Also, the hypermethylation could be observed in all o f the first-trimester 
and third-trimester human placental samples examined. Further, none of the fifteen 
non-TSGs screened were found to be hypermethylated in the placenta. The finding 
suggested that hypermethylation is commonly found in the TSGs of the placenta. 
The placenta is regarded as a globally hypomethylated tissue. Many studies reported 
the overall methylation level of the placenta is comparatively lower than the other 
normal tissues (Rossant et al 1986, Monk et al. 1987). Some even used the D N A 
from placental tissues as unmethylated controls in cancer studies (Kusy et al 2003, 
Russo et al. 2005). Indeed, my findings support that placenta-specific methylation can 
hardly be found in the non-TSGs. However, around 10% of TSGs I studied were 
found to be hypermethylated in the placenta. This phenomenon is surprisingly similar 
to a tumour tissue: with global DNA demethylation and TSG hypermethylation 
(Robertson 2005). This high occurrence of TSG hypermethylation suggested that 
D N A from placenta is not a suitable unmethylated control for methylation studies of 
cancer, particularly on TSGs. 
I have also observed several TSGs that are unmethylated in the placenta but 
methylated in the maternal blood cells as revealed by MSP, for example TUSC2. As 
these MSP results could not be confirmed by bisulfite sequencing, these data were not 
further processed in this study. The lack of concordance between MSP and bisulfite 
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sequencing may be explained by sub-optimal conditions of the MSP assays. 
Interestingly, I observed several genes that were methylated both in the placenta as 
wel l as in the maternal blood cells. Examples are ID4, CDH13, SEMB3B and SFN. 
For SFN, a previous study has shown that its methylation could be observed in several 
normal tissues (Oshiro et al. 2005). It was found that normal cells which did not 
express 7 ^ -J-Jcr had a methylated 14-3-3 <j CpG island with hypo acetylated histories, 
methylated histone H3 lysine 9, and an inaccessible chromatin structure. The authors 
also suggested that these cell type-specific genes which were controlled by normal 
epigenetic mechanisms might represent important loci wi th an epigenetic 
dysregulation in human cancer (Oshiro et al 2005). It is surprising to find that there 
was a considerable number of TSGs methylated in the blood of pregnant women. 
Therefore, it may be interesting to further study the epigenetic profile o f blood from 
pregnant and non-pregnant women as well as its relationship with the corresponding 
gene expression in blood cells. 
Previous studies investigating the role of TSG methylation in hydatid!form moles 
have used normal placentas for baseline comparison. Chen et al reported the presence 
of PTEN hypermethylation in 3 of 21 normal placentas examined (Chen et al. 2005). 
These data are in contrast to those presented in this thesis (Figure 4.1). I further 
performed bisulfite sequencing in the five first- and third-trimester placentas but 
failed to find evidence of PTEN hypermethylation (Appendix II). While the difference 
in sample size might explain the discrepancy in data, it is noteworthy that the earlier 
study (Chen et al. 2005) was based on the use of methylation-sensitive restriction 
enzyme digestion followed by nested PCR. Although a positive control for the 
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methylated sequence and a blank control were included in the analysis, the use o f a 
control for the restriction digestion of the unmethylated sequence was not reported 
(Chen et al. 2005). Besides, I found that the primer set Chen et al used for the study 
could not differentiate the PTEN from its pseudogene (Zysman et al 2002). Thus, it is 
possible that the sequence they studied was only the PTEN pseudogene. This is 
important because the PTEN pseudogene was found to be methylated in many normal 
tissues (Zysman et al 2002). 
To conclude, I systematically screened 46 TSGs and 15 non-TSGs using 
methylation-specific PCR. By comparing the methylation status o f the genes in the 
placenta and maternal blood cells, I found five hypermethylated TSGs, encompassing 
some 10% of total TSGs screened. However, none of the non-TSGs were found to be 
hypermethylated. The finding in this study is consisted a hypermethylation of TSGs in 
the placenta. This phenomenon of placenta is strikingly similar to that o f the tumour 
tissue. 
79 
Methylation status of TSGs in different tissues 
CHAPTER 5: Methylation status of TSGs in different tissues 
5.1 Introduction 
Cell-type-specific methylation refers to the methylation of genes that can be found in 
specific types of normal cells only. It has been demonstrated that cell-type-specifc 
methylation is responsible for controlling the tissue specific gene expression of 
certain genes. Examples include SERPINB5 (Futscher et al 2002), 14-3-3<j (Oshiro et 
al. 2005) . and H0XA5 (Strathdee et al 2007). Recently, it has been found that a TSQ 
RASSFIA, is hypermethylated in the human placenta (Chiu et al. 2007). Unlike the 
cell-type-specific genes mentioned, the hypermethylation of RASSFIA can only be 
found in the placenta, but not in any other tissues studied. It is speculated that the 
placental-specific methylation may be one molecular change that contributes toward 
the pseudomalignant nature of the placenta. 
By comparing the methylation status of TSGs in the placenta and blood cells, I 
discovered five TSGs that are methylated only in the placenta but not in blood cells. 
Furthermore, the methylation can be found in all placental samples from the first- and 
third-trimester. I am interested to know whether these TSGs genes are similar to 
RASSFIA, i.e. the hypermethylation is placental-specific. I f the hypermethylation of 
these TSGs is unique to the placenta, it may further strengthen the idea that 
hypermethylation of TSGs are associated with the pseudomalignant nature of the 
placenta. 
In this chapter, I shall investigate the methylation status of the five TSGs across 
seventeen different normal tissues from abortuses terminated in the second trimester. 
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5.2 Materials and methods 
5.2.1 Sample collection 
Pregnant women with uncomplicated pregnancies who attended the Department o f 
Obstetrics and Gynaecology at the Prince of Wales Hospital, Hong Kong were 
recruited wi th informed consent. The study and the collection of human clinical 
samples were approved by the Joint CUHK-NTEC Clinical Research Ethics 
Committee. Tissues from second-trimester abortuses were collected and processed as 
described in 3.1.1. 
5.2.2 Sample processing and DNA extraction 
D N A extraction procedure of fetal tissues is described in 3.2.1. 
5.2.3 Experimental design 
In order to investigate whether methylation of the five hypermethylated TSGs 
identified in chapter 4 could be found in other tissues, real-time quantitative MSP was 
used to study the methylation status of the five hypermethylated TSGs in seventeen 
different tissues. The seventeen different fetal tissues included the bladder, brain, 
colon, heart, kidney, liver, lung, skeletal muscles, pancreas, placenta, skin, small 
intestine, spleen, stomach, thymus, testis and ovary. The tissues were obtained from 
two abortuses terminated in the second trimester. The DNA from the tissues was 
extracted and undergone bisulfite conversion prior to real-time quantitative MSP. 
PCR primers and probes were designed to amplify both the methylated DNA 
sequences and the unmethylated sequences. An index called the methylation index 
(MI) would then be assigned to each tissue according to the relative methylation 
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proportion. The M I in a sample was calculated by dividing the copy number o f 
methylated molecules by the total number of methylated and unmethylated molecules. 
Therefore, the degree of methylation in different tissue samples could be compared 
irrespective o f the difference in the amount of D N A extracted from different tissues. 
Bisulfite conversion 
Bisulfite modification on extracted D N A was performed using the EZ D N A 
Methylation K i t (Zymo Research, Orange, CA) as described in 3.3.2. 1 |ig of each 
extracted D N A was incubated at 50°C for 16 hours after addition of the CT conversion 
reagent. 
Real-time quantitative MSP 
Real-time quantitative MSP assays (Lo et al 1999c) for APC, CASP8, DAB2IP, 
PTPN6 and SCGB3A1 were developed. The PCR was performed using a TaqMan 
PCR Core Reagent K i t (Applied Biosystems, Foster City, CA, USA) on an A B I 7300 
sequence detection system (Applied Biosystems, Foster City, CA, USA). Procedures 
for the qMSP assay were described in 3.5.2. The primer, probe, and standard 
calibration sequences are listed in Table 5.1, and thermal profiles o f the assays are 
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5.3 Results 
5.3.1 Methylation patterns of TSGs in non-placental fetal tissues. 
Real-time quantitative MSP was performed to study i f the hypermethylation of APC, 
CASP8, DAB2IP’ PTPN6 and SCGB3A1 was only observable in the placenta. A panel 
o f fetal tissues obtained from two second-trimester abortuses with gestational ages o f 
20.7 and 23 weeks were investigated for their methylation indices on the five loci. 
While methylation for APC, DAB2IP and SCGB3A1 was only detected in the 
placental tissues, CASP8 was found to be methylated in the brain, heart and skeletal 
muscles, whereas the methylation of PTPN6 was detectable in all fetal tissues 
examined (Figure 5.1). The methylation indexes of the three hypermethylated TSGs in 
the placenta o f two abortuses were 0.41 and 0.30 for APC, 0.12 and 0.26 for DAB2IP, 
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Figure 5.1. Real-time quantitative MSP analysis of TSGs 
Real-time quantitative MSP analysis of APC (A), CASP8 (B), DAB2IP (C), PTPN6 
(D) and SCGB3A1 (E) in a panel of fetal and placental tissues from the two 
abortuses. The methylation index was calculated by dividing the concentration of 
the methylated sequence by the sum of methylated and unmethylated sequences. 
Abortus #001 is a male and abortus #293 is a female. 
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5.4 Discussion 
111 this part o f study, I found that the hypermethylation o f APC, DAB2IP and 
SCGB3A1 was observable in the placenta only. In the literature, this kind o f specific 
methylation o f genes in a particular normal tissue in human is uncommon. 
Cell-type-specific methylation has been suggested in several genes. However, as the 
name suggested, the methylation is cell-type-specific instead of tissue-specific. For 
example, SERPINB5 is methylated in mesenchymal cells and haematopoietic cells 
(Futscher et al 2002). 14-3-3(5 exhibits a very similar pattern of CpG island 
methylation when compared with SERPINB5 and methylation has been identified in 
both fibroblast and haematopoietic cells (Oshiro et al. 2005). Similarly, the H0XA5 
gene, a member o f the HOX gene family that plays key roles in development and 
differentiation, exhibits CpG island methylation in both haematopoietic and 
mesenchymal cells (Strathdee et al 2007). The MCJ gene exhibited CpG island 
methylation in all epithelial cells (Strathdee et al 2004a). Apparently, the 
placental-specific hypermethylation of TSGs found in this study is a special class of 
tissue-specific methylation and it may implicate an important biological role of the 
corresponding TSGs in the placenta. 
Among the hypermethylated TSGs found in the MSP screening, CASP8 and PTPN6 
were found to be methylated also in other normal tissues. This finding is concordant 
with the previous studies. In the epigenetic study of supratentorial primitive 
neuroectodermal tumours (sPNET) and atypical teratoid/rhabdoid tumours (AT/RT), 
Miihlisch et al compared the methylation status of CASP8 in normal brain tissues and 
in brain tumour tissues. They found that a 5' CpG-rich region of CASP8 was 
methylated in normal tissues and in tumours (Muhlisch et al. 2006). M y results also 
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supported that CASP8 methylation could be found in the brain. In addition, I also 
found a low level of methylation in the heart and skeletal muscles. Similarly, the 
methylation o f PTPN6 in epithelial tissues I found in this study was also revealed by 
another groups studying the methylation changes of PTPN6 in psoriasis 
(Ruchusatsawat et al. 2006). 
Although the methylation of CASP8 and PTPN6 is not unique to the placenta, it may 
still be interesting to study the role of methylation of these two genes in the placenta. 
The apoptosis cascade has been described to be involved in the differentiation o f 
human placental villous trophoblast processes (Huppertz and Kingdom 2004, 
Straszewski-Chavez et al. 2005). The role of CASP8 in the apoptosis of trophoblast 
cells for placental development has been suggested (Straszewski-Chavez et al 2005). 
In terms of pathology, it has also been suggested that the downregulation of CASP8 
might contribute to the pathogenesis of choriocarcinoma (Fong et al 2006). Thus, it 
would be interesting to study the hypermethylation of CASP8 in normal placenta in 
relation to its gene expression and to correlate it to the aetiology of choriocarcinoma. 
Unlike CASP8, the role of PTPN6 in the placenta is not well studied. However, a 
recent study demonstrated an interesting methylation mechanism of PTPN6 which 
involves STATS and D N M T l (Zhang et al. 2005). When applied to the placenta, this 
piece of evidence may aid the study of its methylation establishment in which 
information on it is still scarce. 
Recently, a novel test for the detection of fetal DNA in maternal plasma using 
hypermethylated RASSFIA as a universal fetal marker has been developed (Chan et al 
2006a, Chan et al. 2006b). I believe that the hypermethylated TSGs found in this 
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Study can also be used in this way. In fact, it has been reported by another groups that 
the methylation of RASSFIA and APC could be detected in the sera o f pregnant 
women (Muller et al 2004). However, this previous paper has not provided any 
evidence that the methylated RASSFIA and APC sequences are coming from the 
placenta. It is possible that RASSFIA, APC and the other hypermethylated TSGs 
found could be detected in the plasma of pregnant women. The hypermethylation o f 
APC, DAB2IP and SCGB3A1 can only be found in the placenta. The methylated 
circulating D N A detected, i f any, in the maternal plasma would most l ikely be derived 
from the placenta (Alberry et al. 2007). Many investigators have reported the 
elevation of circulating fetal DNA in maternal plasma of complicated pregnancies, for 
example by preeclampsia and fetal trisomy-21 (Lo et al 1999a, Lo et al 1999b). By 
detecting the amount of hypermethylated TSGs sequences in the maternal plasma, it 
would be useful to act as a non-invasive method to predict the pregnancy outcome. 
Indeed, significant difference of APC methylation was found between the sera of 
women with normal and complicated pregnancies (Muller et al 2004). Further, unlike 
RASSFIA in which aberrant hypermethylation can be found in as many as 37 kinds of 
cancer (Agathanggelou et al. 2005), the hypermethylation of APC can only be 
detected in patients with a relatively limited specification of cancer only (Esteller et al 
2001). In addition, the multiple hypermethylated genes found in this study offer 
alternative choice of fetal markers to choose from in the uncommon situation when 
the pregnant women is suffering from a neoplastic condition. Therefore, the 
hypermethylated TSGs found in this study may be used as alternative markers to 
RASSFIA in the positive control system for fetal DNA detection. 
In summary, I used the real-time methylation-specific PCR to investigate the 
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methylation status o f the five hypermethylated TSGs (APC, CASP8, DAB2IP, 
SCGB3A1 and PTPN6) found in chapter 4 across 17 different human tissues. I 
demonstrated that the hypermethylation of APC, DAB2IP and SCGB3A1 was unique 
to the placenta. Such tissue specific methylation suggested another dimension of 
similarity between the placenta and a tumour. Also, it has opened up clinical 
application on non-invasive prenatal diagnosis. It would be interesting to further 
investigate the functional role of the hypermethylated TSGs in the placenta. 
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CHAPTER 6: Imprinting checking 
6.1 Introduction 
The discovery of placental-specific hypermethylated TSGs prompted me to 
investigate their possible function. Among different classes o f known D N A 
modification involving D N A methylation, genomic imprinting is a possible reason for 
certain genes to be partially methylated in the placenta. Genomic imprinting is an 
example of epigenetic phenomena that are involved in the control o f expression o f 
certain genes in the genome. Genomic imprinting causes differential expression o f 
maternal and paternal genes depending on the epigenetic marking on the parental 
genes. One of the major mechanisms by which these epigenetic marks are established 
is the differential methylation of genes depending on the parent-of-origin. Indeed, 
several imprinted genes have been identified in the placenta, for example, Tssc4 and 
Mash2 (Coan et al. 2005). Some of them even involve placental-specific genes with 
tumour suppressing function (Muller et al. 2000). 
The control o f expression of specific genes by genomic imprinting is unique to 
placental mammals. It is found that the majority of imprinted genes in mammals are 
involved in the control of embryonic growth and development, for example, placental 
development (Tycko and Morison 2002, Isles and Holland 2005) and post-natal 
development (Tycko and Morison 2002, Constancia et al 2004). According to the 
epigenetic characteristics of an imprinted locus, it is expected that such imprinted 
locus should have a MSF of around 0.50 and this characteristic was observed in one 
of the hypermethylated TSGs, APC. Therefore, I am interested in studying whether 
APC is a placental-specific imprinted gene. The most common method to verify an 
imprinted locus is to identify a single nucleotide polymorphism (SNP) in the 
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region-of-interest followed by bisulfite sequencing the entire region, including the 
SNP. Since imprinting involves the differential methylation o f either the maternal or 
paternal allele, an imprinted locus can be identified by studying the methylation 
pattern o f the gene wi th a heterozygous SNP followed by comparing with the parental 
genotypes so as to confirm for the consistency of methylation related to the parental 
origin of the allele. 
Regarding the APC CpG island, the most nearby SNP was found some 600 bp 
downstream of the studied amplicon in chapter 4 of this thesis. However, bisulfite 
conversion commonly disrupts the integrity of genomic D N A (Grunau et al 2001). 
This characteristic makes the study of large PCR amplicons difficult. Therefore, in 
this chapter, I used a method based on the combined use of methylation-sensitive 
restriction enzyme and subsequent SNP detection by the matrix-assisted laser 
desorption ionization/time-of-flight (MALDI-TOF) mass spectrometry in order to 
search for evidence o f allele-specific methylation of APC in the human placenta. I f 
any allele-specific methylation is found, I w i l l further compare it with the parental 
genotype to confirm for the presence of genomic imprinting. 
6.2 Materials and methods 
6.2.1 Sample collection 
Pregnant women with uncomplicated pregnancies who attended the Department of 
Obstetrics and Gynaecology at the Prince of Wales Hospital, Hong Kong were 
recruited with informed consent. The study and the collection of human clinical 
samples were approved by the Joint CUHK-NTEC Clinical Research Ethics 
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Committee First-trimester placental tissues and third-trimester placental tissues were 
collected and processed as described in 3.1.1. 
6.2.2 Sample processing and DNA extraction 
D N A extraction procedure of placental tissues is described in 3.2.1. 
6.2.3 Experimental design 
To investigate the possibility of genomic imprinting in the APC locus, a method 
combining the use of methylation-sensitive restriction enzyme and homogenous 
MassEXTEND with MALDI -TOF MS was used. The principle of this experiment was 
to investigate whether the methylated DNA sequence in APC was allele-specific. 
Briefly, D N A extracted from the placental tissues was subjected to enzyme digestion 
in order to remove all the unmethylated DNA molecules. The remaining methylated 
D N A molecules would then be amplified by PCR so that the amplicon would contain 
a single nucleotide polymorphism (SNP). Therefore, the methylated D N A molecules 
could be genotyped by homogenous MassEXTEND with MALDI -TOF MS. 
BstUI (New England Biolabs, Ipswich, M A ) was used as the methylation-sensitive 
restriction enzyme in the enzyme digestion process. ^^^UI could recognize CGCG in 
the D N A sequence and cleave the recognition sequence in the middle. However, its 
cleavage activity would be blocked by the presence of CpG methylation. Therefore, it 
could only cleave the CGCG site i f the cytosines in the CG dinucleotides were 
unmethylated. The enzyme was chosen because the enzyme recognition site was only 
present within the hypermethylated region of the APC amplicon. The procedure for 
methylation-sensitive restriction enzyme digestion is described in 3.5.2. 
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After enzyme digestion, the samples would be subjected to genotyping. A n 
informative A /G SNP, rs2019720, was chosen for genotyping of the APC locus 
according to the information from the Human Genome March 2006 (hgl8) assembly 
in the UCSC Genome Browser. It was the most nearby SNP from the APC CpG island 
and was found some 600 bp downstream of the studied amplicon. To account for the 
possibility o f incomplete enzyme digestion by Bst\J\, another assay was designed on a 
known imprinted locus, the H19 gene, to serve as a positive control for this 
experiment. The SNP chosen in the H19 assay was rs2107425, a C/T SNP located in 
the differentially methylated region (DMR) of HI 9. One BstUI cutting site was 
present within each o f the amplicons. Analysis was performed on two cases o f 
first-trimester placental tissue samples and two cases of third-trimester placental 
tissue samples that were heterozygous both at the rs2019720 on the APC locus and 
rs2107425 on H19. PCR amplification of APC and H19 was performed wi th primers 
listed in Table 6.1 prior to genotyping. The PCRs were designed to amplify a segment 
QfAPC and H19 surrounding the SNPs rs2019720 and rs2107425, respectively. 
SNP detection for genotyping in the 万对Ul-digested placental tissues was carried out 
by a primer extension reaction, using the homogenous MassEXTEND method 
followed by MALDI -TOF MS analysis as described in 3.5.1. Theoretically, all o f the 
unmethylated alleles in an imprinted locus would be cleavaged after BstUl digestion. 
The remaining molecules should be associated with either the maternally or paternally 
inherited SNPs. I f the locus was not imprinted, the undigested molecules would 
comprise of both the maternally and paternally inherited SNPs. 
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Analysis was performed on two cases of first-trimester placental tissue samples and 
two cases of third-trimester placental tissue samples. A l l samples were heterozygous 
both at rs2019720 on APC and rs2107425 on H19. 
6.3.1 Imprinting checking of HI9 by enzyme digestion on placental tissues 
Both the T and C alleles were present in all placental tissue samples in the mass 
spectra obtained from MALDI -TOF MS analysis before enzyme digestion by BstUl 
(Figure. 7.1). Since H19 is an imprinted gene, the unmethylated H19 alleles, either T 
or C, should be digested by BstVl. As expected, the mass spectra shown in Figure 7.1 
indicated that only the T or C alleles was present in the 5站Ul-digested placental 
tissue samples. The absence of one allele indicated the complete enzyme digestion of 
unmethylated molecules by RstUI. Thus, the assay was suitable for acting as a 
positive control for an imprinted locus. 
100 
Imprinting Checking 
Before BstUl digestion After BstUl digestion 
I--. L-. 
<D Q> 
I T C 1 T C 
Q. ... , — Q-
First trimester j I 
Placenta ；^： j • | : 
Case 1 I 。 1 1 1 j 
: ; t I ，， ； I 
• ？4於叙的膽‘vm 雄働碰 v m _ sffixj ‘ / 4 u ‘ ^  ^m職禱纖翻喻 mu • 
First trimester J. | | ““…… “ “‘ —"“‘"‘‘ “ j 
Placenta ‘ i I , 丨 I 
Case 2 1 I I ： ！ f 
\ % . I j ？ I： , I 
— - / ' ' � ‘ ‘ « ‘ - , ‘ “ ‘” ) I / , , , … , “ , “ , , y 豪 
• • A • ：“ - y ‘ • ‘ , '“‘ ‘ • ‘ / “ '""“ ™/" “‘ “ / r' /！‘^" “ ' " " " ‘ / /, / / ‘ ‘ // 
Third trimester - ~ j 
Placenta ；, ： r I j 
Case 3 ! ！ I ( 
^ ^ ^ ^ J 令 . ^ ^ …^r 〜办炉* 私 A州 "〜“ 多Zi*•从，办 ^ * / V ^ 久、《 产 , ‘ 办 卿 力 々 參 ^ ^ ^ — 
.錄.S:: l^fM-r : : : 敎 ： 祐 . : . 《•？然众： '--M^l "f^/yfx； 'A//：' 父 y i X / y . <.：>'；!：； ？ i / ^ / ' i ？'Xf：? 
l £ ^ ^ ， 。 
Third trimester / f： \ /c | j 
Placenta I i： i L H 1 | 
Case 4 。… , , , / 着 ^^  ^ 於 ,终、乂 乃 … - “ 々 ， — 今 , 一 , , “ 




：“ ‘ … 、 ： 一 … j 
i v 力 V y X W i V<々 ^JjJ： ttyj 《少J'J》”筋 
Figure 6.1. Genotyping of H19 before and after BstVl digestion. 
For all mass spectra, "Mass" (x-axis) represents the molecular weight of a marked 
peak. “Intensity” (y-axis) is in arbitrary units. Expected locations of the unextended 
primer are marked "primer". Locations of peaks of the extended products of the 
respective SNP alleles are marked using corresponding nucleotide symbols, namely, 
"T " and “C”. 
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6.3.2 Imprinting checking of APC by enzyme digestion on placental tissues 
From the mass spectra, both A and G alleles were detectable in all placental tissue 
samples tested before and after enzyme digestion. The presence of both alleles 
subsequent to enzyme digestion can be interpreted as incomplete digestion by BstUL 
Since the number of 5对UI recognition sites in the two assays was identical and the 
completeness of BstUI enzyme digestion of the unmethylated molecules was 
confirmed by the HI9 assay, the question of incomplete enzyme digestion of ^^^UI 
could be ruled out. However, it was observed that the relative peak heights of the two 
polymorphic bases A and G as shown in the mass spectra were different before and 
after enzyme digestion. 
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peak. "Intensity" (y-axis) is in arbitrary units. Expected locations o f the unextended 
primer are marked "primer". Locations o f peaks o f the extended products o f the 
respective SNP alleles are marked using corresponding nucleotide symbols, namely, 




Genomic imprinting is a possible reason for certain genes to be partially methylated in 
the placenta. Indeed, many imprinted genes have been identified in the placenta (Coan 
et al 2005). Some of them even involve placental-specific genes with tumour 
suppressing function (Muller et al 2000). Imprinted genes are caused mostly by 
methylation and silencing of either of the parental alleles. However, it is believed that 
genes wi th the proportion of methylated clones that deviate greatly from 50% in 
bisulfite sequencing are unlikely to be imprinted genes (Rugg-Gunn et al. 2005). In 
general, the MSFs for all the hypermethylated genes, except APC, were much 
deviated from 0.50. Thus, in this part of my thesis, I focused on studying i f there may 
be a possibility that the placental methylation profile of APC may be explained by 
genomic imprinting. M y investigations revealed a skewed allelic ratio after 
methylation-sensitive enzyme digestion for APC. The phenomenon can be explained 
with several possiblities. 
It is possible that the APC is monoallelically methylated in one or more cell type(s) 
found within the placental tissue biopsy. Monoallelic methylation of APC does exist 
in some of the non-placental normal tissues. Clement et al detected the presence of 
monoallelic APC promoter methylation in normal gastric mucosa (Clement et al 
2004). The monoallelic methylation is not due to imprinting but is most likely due to 
allelic exclusion, which is defined as a stable inactivation by methylation of one allele, 
independent of the parental origin (Clement et al. 2004). Thus the allelic exclusion for 
the APC gene can also be cell-type-specific within a heterogeneous tissue. In gastric 
mucosa, epithelial cells differentiate in several directions, with cells migrating upward 
toward the luminal surface to create the foveolar epithelium and downward to form 
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the glandular cells (Karam 1999). Depending on the direction of differentiation, either 
one or the other APC allele is excluded. 
The study o f APC methylation in normal gastric mucosa may give us some clues in 
the function o f APC hypermethylation in the placenta. In fact, after enzyme digestion, 
I found that the two polymorphic bases A and G were not present with the same ratio 
as that before enzyme digestion within the APC methylated alleles. It may imply that 
the alleles are not methylated at a 1:1 ratio. This is quite similar to the result o f the 
gastric mucosa study (Clement et al 2004). In fact, the placental development also 
involves trophoblastic cells differentiation into several directions, syncytiotrophoblast 
to form chorionic v i l l i or extravillous cytotrophoblasts for proliferation or invasion. 
Thus, this may also depend on exclusion of either one or the other APC. 
Another possibility for causing the skewed allelic ratio after methylation-sensitive 
enzyme digestion may be the placenta composed of different cell populations in terms 
of the methylation status of the APC gene. It is possible that allele-specific 
methylation does exist in certain cell types of placental tissue, but mixing with 
non-allele-specific methylated cell types within the studied samples causing the 
altered ratio after BstXJl enzyme digestion. Similar observation can also be found in 
the clonality analysis on X chromosome inactivation of the polymorphic X-linked 
human androgen receptor (HUMARA) gene. False polyclonality can also be resulted 
from the mixed cell populations with different methylation states of HUMARA gene in 
aberrant crypt foci of the human colon (Sakurazawa et al. 2000). 
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To prove the above possiblities, microdisection of trophoblastic cells and study o f 
allele-specific methylation may be needed. Also, a cut-off value for determining the 
presence or absence of allele-specific methylation after methylation-sensitive enzyme 
digestion should be needed to improve the interpretation of the results. I f 
allele-specific methylation is confirmed among certain placental cell types, to further 
confirm the existence of genomic imprinting, the parental genotype should be 
compared wi th the studied samples in order to assess the parental origin of the 
methylated allele. However, due to the complexity of these experiments, they have not 
been carried out in this thesis. 
To conclude, I developed an assay to check for the possibility of imprinting in the 
APC loci. This method overcame the difficulties of using conventional bisulfite 
sequencing method to check for imprinting evidence. Using an imprinted gene, HI9, 
as a positive control, I found an interesting methylation pattern in APC which 
warrants further investigation. 
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CHAPTER 7: Correlation of hypermethylation and gene expression 
7.1 Introduction 
The placenta-specific methylation profile of TSGs may suggested the existence o f an 
interesting gene regulation mechanism by methylation in a non-malignant tissue. 
Cytosine methylation at the dinucleotide CpG island is an important regulator o f gene 
expression in higher eukaryotes, which has been shown to directly affect gene 
expression either by preventing binding of necessary transcription factors to the 
promoter, or more frequently, by involving methylated DNA-binding proteins that 
recruit accessory factors for transcriptional silencing (Wade 2001). This latter 
mechanism can lead to local recruitment ofhistone deacetylase (HDAC). Accordingly, 
the silencing of TSGs by hypermethylation is well described in human cancer and may 
involve the transcriptional repressor MeCP2, which is associated in vivo with 
chromatin modifiers and transcriptional corepressors (Nguyen et al 2001). However, 
it is also found that cell-type-specific methylation is not necessarily correlated with 
the gene expression (Dokras et al. 2006). Therefore, to prove the importance o f this 
class of methylation, it is necessary to study the association between the 
hypermethylation of TSG and its gene expression. 
In cancer research, the study of gene expression in relation to its methylation can be 
done by cancer cell culturing with demethylating agent treatment. However, it is 
difficult to culture the primary human trophoblast cells due to its paucity and poor 
viability (Choy and Manyonda 1998). The difficulty in culturing primary human 
trophoblast cells prompted me to further investigate the relationship between APC 
methylation and its gene expression in two choriocarcinoma cell lines, JAR (Pattillo et 
al. 1972) and JEG3 (Kohler and Bridson 1971). 
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7.2 Materials and methods 
7.2.1 Sample preparation and processing 
The cell line preparation on JAR and JEG3 and the treatment of JAR and JEG3 with 
5-aza-2'-deoxycytidine (5-aza-CdR) and Trichostatin A (TSA) are described in 3.1.4. 
7.2.2 DNA and RNA extraction from cell lines 
The procedures D N A and RNA extraction from cell lines are described in 3.2.1 and 
3.2.3, respectively. 
7.2.3 Experimental design 
The correlation of DNA methylation in the APC promoter and its gene expression was 
investigated by demethylation experiment followed by real-time reverse transcriptase 
(RT)-PCR. It is believed that promoter methylation of genes could suppress gene 
expression. One of the ways to demonstrate this relationship is to see whether gene 
expression w i l l be restored when the gene promoter becomes unmethylate. Therefore, 
in this study, I would demethylate the promoter of APC in the placental lineage by 
using demethylating drugs, 5-aza-CdR and TSA. The DNA extracted from the cell 
lines would then be subjected to bisulfite conversion as described in 3.3.2. The 
methylation status of the cell lines before and after drug treatment would be 
investigated by cloning and bisulfite genomic sequencing as described in 3.3.5. The 
degree of methylation in each sample would be represented by MSF so that I could 
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objectively compare the methylation status of the cell lines before and after drug 
treatment to ensure demethylation of promoter was successful. Also, the gene 
expression of APC before and after dug treatment was measured by real-time RT-PCR 
as described in 3.4.3. The primer sequences used in the assay is listed in Table 7.1 and 
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7.3 Results 
7.3.1 Methylation status oiAPC in choriocarcinoma cell lines 
To check the methylation status of the choriocarcinoma cell lines, bisulfite sequencing 
was performed on the two cell lines, JEG3 and JAR, before and after drug treatments. 
The bisulfite sequencing result indicated that the APC CpG island was heavily 
methylated for both cell lines before any treatment. The MSF was 0.904 in JEG3 
(Figure 7.1) and 0.928 in JAR (Figure 7.2). 
After treatment of 1 jumol/L of 5-aza-CdR, the MSF was reduced to 0.4 in JEG3 
(Figure 7.1) and 0.464 in JAR (Figure 7.2). With 3 |Limol/L of 5-aza-CdR, MSF was 
reduced to 0.676 in JEG3 (Figure 7.1) and 0.852 in JAR (Figure 7.2). For the cell 
lines treated with 1 |imol/L of 5-aza-CdR plus 50 ng/ml TSA, the MSF was 0.148 in 
JEG3 (Figure 7.1) and 0.392 in JAR (Figure 7.2). For the cell lines treated with 1 
|L imol /L of 5-aza-CdR plus 100 ng/ml TSA, MSF was 0.44 in JEG3 (Figure 7.1) and 
0.084 in JAR (Figure 7.2). In short, the methylation was reduced after drug 
treatments. 
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Figure 7.1. Methylat ion status of the APC promoter in the JEG3 cell line w i th 
and wi thout treatment of 5-aza-2'-deoxycytidine and tr ichostatin A. 
Circles along one column represent one CpG site (f i l led circles, methylated; open 
circles, unmethylated). Each row represents one clone.十The position of analyzed 
CpG sites are assigned according to the APC {Homo sapiens) GenBank Accession 
NM—000038 with the start codon of its protein coding sequence as position +1. The 
first CpG site (-17372) corresponds to chr5:112101115 of the human genome in the 
UCSC Genome Browser (March 2006 assembly, hgl8). 
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Figure 7.2. Methylat ion status of the APC promoter in the J A R cell l ine w i th and 
wi thout treatment of 5-aza-2'-deoxycytidine and tr ichostatin A. 
Circles along one column represent one CpG site (filled circles, methylated; open 
circles, unmethylated). Each row represents one clone.十The position of analyzed 
CpG sites are assigned according to the APC {Homo sapiens) GenBank Accession 
NM—000038 with the start codon of its protein coding sequence as position +1. The 
first CpG site (-17372) corresponds to chr5:112101115 of the human genome in the 
UCSC Genome Browser (March 2006 assembly, hgl8). 
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7.3.2 Demethylation of APC in choriocarcinoma cell lines 
APC mRNA was undetectable in both cell lines by real-time RT-PCR before any 
treatment. Treatment of these cell lines with 5-aza-CdR, with and without TSA 
resulted in re-expression of APC mRNA in JAR and JEG3, respectively (Figure 7.3). 
This experiment thus demonstrated the reciprocal relationship between promoter 
methylation and gene expression at the APC locus in malignant cells of the 
trophoblastic lineage. 
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Figure 7.3. Expression of AFC mRNA in JAR and JEG3 after treatment with 
5-aza-2'-deoxycytidine and trichostatin A. 
APC and GAPDH mRNA levels were measured by real-time RT-PCR. Low-dose TSA: 100 
ng/ml, 24 hours for JAR; 50 ng/ml, 7 hours for JEG3; high-dose TSA: 500 ng/ml, 24 hours 
for JAR; 100 ng/ml, 7 hours for JEG3. 
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7.4 Discussion 
In this part of the thesis, I investigated the relationship between DNA methylation and 
gene expression in APC. To study the function of hypermethylation in a normal cell, 
primary human trophoblast cells should be used. However, culturing primary human 
trophoblast cells is difficult because of the paucity and poor viability of the cells 
(Choy and Manyonda 1998). Thus, choriocarcinoma cell lines, JAR and JEG3, were 
used in this study. APC was densely methylated (-90%) with no gene expression in 
the untreated choriocarcinoma cell lines. After treating with the demethylation agent, 
5-aza-CdR, APC expression was seen. I have provided evidence that APC expression 
and activity were inversely correlated with the presence of methylation at the 
promoter. These results were consistent with the suggestion that promoter methylation 
could be involved in the APC gene expression in trophoblastic cells. 
I believe that the study findings may be of relevance to investigators studying the 
biology of APC and postulate that APC hypermethylation in the human placenta may 
play a significant biological role. APC is an important component of the Wnt 
signalling pathway (Pollheimer et al. 2006). It is reported that Wnt signalling pathway 
may be involved in placental development (Cross et al 2003). Further, APC regulates 
Wnt signalling by interacting with beta-catenin. A study on colon carcinoma reported 
that beta-catenin expression modulates the expression of inhibitor of DNA binding 2 
(ID2) (Rockman et al. 2001). Incidentally, ID2 has been reported to be an important 
helix-loop-helix protein that regulates cytotrophoblast differentiation and function 
(Janatpour et al 2000). Thus, there exists a possibility that APC may indeed play a 
significant biological role in cytotrophoblast development through its indirect effects 
on ID2. Further studies should therefore be directed to address if ID2 expression in 
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placental tissues is similarly modulated by APC, as in the case for colon carcinoma 
cells. 
DNA methylation of TSG may function as a regulator of age-related changes in 
normal aging cells. Age-dependent methylation of the APC gene promoter has been 
reported in the stomach and lung (Tsuchiya et al. 2000, Brabender et al. 2001, Waki et 
al. 2003). For example, Waki and colleagues noticed /iPCmethylation in almost all of 
the gastric mucosa samples from patients over the age of 40 years, but in <50% of 
younger patients. From my data, the methylation of the APC promoter in the placenta 
can be observed in as early as the first trimester. Therefore, it is unlikely that the 
hypermethylation is related to aging. 
My data also suggest a pathological role of APC in choriocarcinoma development. 
Loss of APC gene expression and promoter methylation has been observed in a 
variety of cancers and precancerouse lesions (Tsuchiya et al. 2000, Maruyama et al. 
2001, Virmani et al. 2001). Previous studies have also investigated the role of TSG 
methylation in choriocarcinoma. However, the role of APC in the disease has not been 
reported. In the present study, promoter hypermethylation of APC was observed in 
both choriocarcinoma cell lines (JAR and JEG3). The MSF of APC found in the cell 
lines was even higher than that in the normal placenta. By treating the 
choriocarcinoma cell lines with a DNA methyltransferase inhibitor, 5-aza-CdR, I 
showed that the induction of APC expression correlated with the decrease in 
methylation. APC expression was markedly increased after the treatment. These 
results are consistent with the involvement of promoter methylation in the suppression 
of APC in choriocarcinoma cell lines. To my knowledge, it is the first study showing 
the involvement of promoter methylation of APC in choriocarcinoma. Instead of 
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working on cell lines, further investigation on primary choriocarcinoma tissues is 
needed in order in order to confirm the involvement of APC in this case. 
In conclusion, I have studied the relationship of methylation and gene expression of 
hypermethylated TSG using APC as a study model. I found an inverse relationship 
between DNA methylation and gene expression in APC. The finding suggested that 
DNA methylation played an important role in the regulation of gene expression in this 
TSG Moreover, the study of methylation status in choriocarcinoma cell lines 
suggested that methylation of APC might also play a role in the pathology of 
choriocarcinoma. 
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CHAPTER 8: Methylation analysis of hypermethylated TSG 
homologues in the placentas of the mouse and rhesus monkey 
8.1 Introduction 
It was demonstrated that hypermethylation of TSGs existed in the normal human 
placenta. Some of the hypermethylated TSGs found are even methylated uniquely in 
the placenta. This phenomenon suggests a possible role of hypermethylated TSGs in 
the development of placenta. It would be interesting to study the in vivo function of 
these TSGs in the placenta. One of the common ways to investigate the in vivo 
function of a gene is to do a knockout gene experiment in the placenta of a model 
organism. 
The mouse is frequently used as a model organism for human disease. Identifying the 
functions of unknown human genes is being carried out largely by inactivating the 
equivalent genes in the mouse. Researchers can then observe and investigate the 
subsequent biological and molecular changes after knocking out the concerned gene 
in order to deduce its function. An animal that is even more closely related to human 
is the rhesus monkey. Although rhesus monkey is not yet used in knockout 
experiment, recent advance in gene transfer and gene silencing approaches may 
allow "transient knockout" experiments in the rhesus monkey (Chan et al. 2001, 
Rubinson et al. 2003). Besides, it would be interesting to study the conservation of 
TSG hypermethylation across different organisms. 
Before contemplating experiments on these model organisms, it is important to 
confirm the existence of TSG hypermethylation in the respective animal models. In 
this chapter, I aim to investigate whether the hypermethylated TSGs can also be found 
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the placenta of the mouse and rhesus monkey. 
8.2 Materials and methods 
8.2.1 Sample collection 
Murine placental tissues (E18.5) were obtained from pregnant mice (ICR) at the 
Laboratory Animal Services Centre of The Chinese University of Hong Kong with 
institutional animal ethics approval and were sacrificed near term. Among the seven 
placentas collected, two were bisulfite sequenced individually and the remaining five 
were pooled before bisulfite sequencing. Rhesus tissues were obtained from the 
Guangdong-Zhaoqing Laboratory Animal Research Center in China using procedures 
stipulated by the Convention on International Trade in Endangered Species of Wild 
Fauna and Flora and the animal ethics committee at The Chinese University of Hong 
Kong. Pregnant rhesus monkeys were sacrificed near term. Peripheral blood samples 
were collected from two pregnant rhesus monkeys. Placenta, liver, and heart tissues 
were collected from the fetuses of each pregnancy. 
8.2.2 Sample processing and DNA extraction 
Blood sample processing is described in 3.1.2 DNA extraction procedures of blood 
samples and placental tissues are described in 3.2.1 and 3.2.2, respectively. 
8.2.3 Experimental design 
Cloning and bisulfite genomic sequencing was performed to investigate the 
methylation status of TSGs in several tissues of the rhesus monkey and the mouse. 
DNA extracted from the tissues and blood samples were subjected to bisulfite 
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genomic sequencing. Bisulfite modification on the extracted DNA was performed by 
using the EZ DNA Methylation Kit (Zymo Research, Orange, CA) as described in 
3.3.2. 1 |ig of each extracted DNA was incubated at 50°C for 16 hours after addition 
of the CT conversion reagent. Cloning and bisulfite genomic sequencing on the 
bisulfite converted DNA was performed as described in 3.3.6. The PCR primers are 
listed in Table 8.1 and the PCR conditions of bisulfite sequencing reactions for the 
TSGs are summarized in Table 8.2. MSF of different genes was defined for each 
sample in order to objectively compare the degree of methylation in different tissues 
and animals. The MSF was calculated by dividing the total number of methylated sites 
over all cloned CpG sites. 
121 
Methylation analysis of hypermethylated TSG homologues in the placenta of llie mouse and rhesus monkey 
Table 8.1 Primer sequences for bisulfite sequencing (rhesus & mouse) 
Oligo Sequence (5' to 3') Product length (bp) 
APC 
RhPromoter-F ITTTTTTTTTTATTTTTAGTATTTTGTGTTAATTT “ 345 
RhPromoter-R CACCCTAACRAACTACACCAATACAA 
MmPromoter-F AGAATTATGTTTTTTTGTTGTATTTGAATT 388 
MmPromoter-R ACAAACTACRCCAATACAACCACATA 
CASP8 
RhPromoter-F IAGGGAAGTGTTTTTATAGGTTTTTT 305 
RhPromoter-R TC^WvAACAAAAATATATAATTTCCTATTA 
DAB2iP 
MmPromoter-F [AAGGGTTTTATTAAGYGTATTAAGAGTT 258 
MmPromoter-R |AATCCCRATCCCCCAA | 
PTPN6 
RhPromoter-F [TTTTGTTTGTGAGATGATAAAGATAGTT 250 
RhPromoter-R C^^CCCAAATCATACTTCATACATATA 
MmPromoter-F TGAGGTTTTGGTGATTTGTAATTTAT 267 
MmPromoter-R ACACAAAAACAAAACAATAAATATTCATA 
SCGB3A1 
RhPromoter-F ITGATATTGTTAYGGTTTGGGATTAT 210 
RhPromoter-R AACAAAAACTAAAACCCAAAACTAAA 
MmPromoter-F G ^ A T T T A G A G T T T T T G G G A T T T G T 250 
M m P r o m o t e r - R | T A A C A A A A T C T C C T A A A C T C A A A T A C T A A A 
Notes on oligo suffix, sequence prefix and suffix: 
F Forward primer 
R Reverse primer 
Rh rhesus macaque 
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8.3 Results 
8.3.1 Methylation status of TSGs in rhesus monkey and murine placental tissues 
I studied whether hypermethylation of TSGs might be observable in the murine placenta. 
DNA from seven El8.5 murine placentas were subjected to cloning and bisulfite 
sequencing and revealed the lack of TSG hypermethylation. To explore whether 
hypermethylation of TSGs might be observed in other primates, cloning and bisulfite 
sequencing was performed on term placental tissues collected from two rhesus monkeys 
{Macaca mulatto) and the bisulfite sequencing result of the TSGs in the two animals are 
shown from Figure 8.1 to Figure 8.6. 
Remarkably similar to the human placenta, APC hypermethylation was observed in the 
rhesus placental tissues but not in the blood cells of the pregnant monkeys. However, no 
methylation of Ape was observed in the placenta tissues of the mouse (Figure 8.1). 
Since the homologue of the studied region of CASP8 was missing in the mouse, only 
rhesus tissues were investigated for methylation status of Casp8. Surprisingly, CASP8 
methylation in the rhesus placenta is not observed, i.e. only a few CpG sites were 
methylated. Similarly, almost no Casp8 methylation could be observed in the blood 
cells, brain, heart and liver (Figure 8.2). 
The bisulfite sequencing of the DAB2IP locus in rhesus was not yet completed, so only 
the mouse homologue was shown. The bisulfite sequencing result showed that the CpG 
island of Dab2ip was completely unmethylated in the mouse placenta, which was in 
accordance with that of APC in mouse (Figure 8.3). 
The hypermethylation of PTPN6 could be found in the placental tissues but not in the 
blood cells of the pregnant rhesus monkeys. Unlike APC in which methylation was 
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absent in the placental tissues of the mouse, hypermethylation of PTPN6 was also 
observed in the murine placental tissues (Figure 8.4). 
Unexpectedly, the hypermethylation of SCGB3A1 was not observed in the rhesus 
placenta. In contrast to Casp8, ScghSal was densely methylated in both the rhesus 
placenta and blood cells. Also, we could observe dense methylation of ScgbSal in the 
placental tissues (Figure 8.5). 
The inconsistent conservation of TSG hypermethylation in the two animals prompted 
me to further investigate the methylation status of SERBINB5, a hypomethylated gene 
in the human placenta, in the two animals. Comparing to the blood cells (MSF = 0.963 
and 0.955), SerpinbS was hypomethylated in the rhesus placenta (MSF = 0.437 and 
0.667). In the mouse, methylation of serpinb5 could also be detected in the placental 
tissues with MSF 0.346 to 0.536. The range of MSF was generally lower than that in the 
brain (MSF = 0.817 and 0.773), heart (MSF 二 0.683 and 0.538) and liver (MSF = 
0.673). Therefore, it may indicate that placental hypomethylation of Serpinb5 was 
conserved in the rhesus and mouse, while the TSG hypermethylation was not (Figure 
8.1). The bisulfite sequencing data in this study was summarized in Table 8.3. 
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Figure 8.1. Bisulfite sequencing of the Ape promoter in murine and rhesus placentas. 
( f i l l e d circles, m e t h y l a t e d ; open circles, u n m e t h y l a t e d ) . A : T i s s u e s f r o m t h e p l a c e n t a a n d t h e 
c o r r e s p o n d i n g m a t e r n a l b l o o d c e l l s f r o m t w o r h e s u s m o n k e y f e t u s e s w e r e a n a l y z e d . ' T h e r h e s u s Ape 
g e n o m i c s e q u e n c e w a s d e r i v e d b a s e d o n a l i g n i n g t h e APC p r o t e i n s e q u e n c e f o r Homo sapiens 
( G e n B a n k a c c e s s i o n : N P — 0 0 0 0 2 9 ) w i t h t h e g e n o m e o f Macaca mulatta ( U C S C g e n o m e b r o w s e r , 
J a n u a r y 2 0 0 6 a s s e m b l y , r h e M a c 2 ) . T h u s , t h e C p G s i tes are n a m e d w i t h t h e s ta r t c o d o n o f t h e APC 
p r o t e i n s e q u e n c e {Homo sapiens) as p o s i t i o n + 1 . T h e f i r s t C p G s i t e ( - 1 9 2 3 5 ) c o r r e s p o n d s t o 
C h r 6 : 1 0 9 0 5 1 6 7 3 o f r h e M a c 2 . B : S e v e n E 1 8 . 5 m o u s e p l a c e n t a s f r o m o n e l i t t e r w e r e s t u d i e d . T w o 
p l a c e n t a s w e r e a n a l y z e d i n d e p e n d e n t l y , a n d t h e r e m a i n i n g f i v e w e r e p o o l e d . ^ T h e m u r i n e Ape g e n o m i c 
s e q u e n c e w a s d e r i v e d b a s e d o n a l i g n i n g t h e APC p r o t e i n s e q u e n c e f o r Homo sapiens ( G e n B a n k 
a c c e s s i o n : N P — 0 0 0 0 2 9 ) w i t h t h e g e n o m e o f Mus muscuius ( U C S C g e n o m e b r o w s e r , F e b r u a r y 2 0 0 6 
a s s e m b l y , m m 8 ) . T h u s , t h e C p G s i tes are n a m e d w i t h t h e s ta r t c o d o n o f t h e APC p r o t e i n s e q u e n c e 
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Figure 8.3. Bisulfite sequencing of the Dablip promoter in murine placentas. 
(filled circles, me thy la ted ; open circles, unmethy la ted) . A: Seven E18.5 mouse 
placentas f r o m one l i t te r were studied. T w o placentas were ana lyzed independent ly , and 
the r e m a i n i n g f i v e were poo led . ^The mu r i ne Dab2ip genomic sequence was de r i ved 
based o n a l i g n i n g the DAB2IP p ro te in sequence fo r Homo sapiens ( G e n B a n k accession: 
N P _ 6 1 9 7 2 3 ) w i t h the genome o f Mus muscuius ( U C S C genome browser , February 
2006 assembly, m m 8 ) . Thus , the C p G sites are named w i t h the start codon o f the 
DAB2IP p ro te i n sequence {Homo sapiens) as pos i t i on +1 . The f i rs t C p G site ( - 46103 ) 
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Chrl 1:7134227 of rheMac2. B: Seven E18.5 mouse placentas from one litter were 
studied. Two placentas were analyzed independently, and the remaining five were 
pooled. ^The murine Ptpn6 genomic sequence was derived based on aligning the 
PTPN6 protein sequence for Homo sapiens (GenBank accession: NP—536859) with the 
genome of Mus muscuius (UCSC genome browser, February 2006 assembly, mm8). 
Thus, the CpG sites are named with the start codon of the PTPN6 protein sequence 
{Homo sapiens) as position +1. The first CpG site (-505) corresponds to 
Chr5:124699077 ofmmS. 
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Figure 8.5. Bisulfite sequencing of the ScgbSal promoter in murine and rhesus 
placentas. 
(filled circles, m e t h y l a t e d ; open circles, u n m e t h y l a t e d ) . A: T issues f r o m the p l acen ta 
a n d the c o r r e s p o n d i n g m a t e r n a l b l o o d ce l ls o f t w o rhesus m o n k e y fetuses w e r e 
ana lyzed . ' T h e rhesus ScgbSal g e n o m i c sequence w a s d e r i v e d based o n a l i g n i n g the 
SCGB3A1 p r o t e i n sequence f o r Homo sapiens ( G e n B a n k access ion: NP一443095 ) w i t h 
the g e n o m e o f Macaca mulatta ( U C S C g e n o m e b rowser , January 2 0 0 6 assembly , 
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rheMac2). Thus, the CpG sites are named with the start codon of the SCGB3A1 protein 
sequence {Homo sapiens) as position +1. The first CpG site (-403) corresponds to 
Chr6:177291675 of rheMac2. B: Seven El8.5 mouse placentas from one litter were 
studied. Two placentas were analyzed independently, and the remaining five were 
2 • . . pooled. The murine ScgbSal genomic sequence was derived based on aligning the 
SCGB3A1 protein sequence for Homo sapiens (GenBank accession: NP—443095) with 
the genome of Mus mus cuius (UCSC genome browser, February 2006 assembly, mm8). 
Thus, the CpG sites are named with the start codon of the SCGB3A1 protein sequence 
{Homo sapiens) as position +1. The first CpG site (-430) corresponds to 
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Figure 8.6. Bisulfite sequencing of the SerpinbS promoter in rhesus placentas, murine placentae 
brain, heart and liver 
(filled circles, methylated; open circles, unmethylated). A: Tissues from the placenta and th 
c o r r e s p o n d i n g m a t e r n a l b l o o d c e l l s o f t w o r h e s u s m o n k e y f e t u s e s w e r e a n a l y z e d . ^ T h e r h e s u s Serpinb, 
genomic sequence was derived based on aligning the SERPINB5 protein sequence for Homo sapien 
(GenBank accession: NP—033283) with the genome of Macaca mulatta (UCSC genome browsei 
January 2006 assembly, rheMac2). Thus, the CpG sites are named with the start codon of the SERPINB. 
protein sequence {Homo sapiens) as position +1. The first CpG site (-8473) corresponds t( 
C h r l 8 : 5 6 8 5 7 6 3 0 o f r h e M a c 2 . B : S e v e n E l 8 . 5 m o u s e p l a c e n t a s f r o m o n e l i t t e r t o g e t h e r w i t h tissue： 
from brains, hearts and liver of two mice were studied. Two placentas were analyzed independently, an( 
the remaining five were pooled. ^The murine Serpinb5 genomic sequence was derived based on aligning 
the SERPINB5 protein sequence for Homo sapiens (GenBank accession: NP—033283) with the genomi 
of Mus mus cuius (UCSC genome browser, February 2006 assembly, mm8). Thus, the CpG sites ar( 
named with the start codon of the SERPINB5 protein sequence {Homo sapiens) as position +1. The firs 
CpG site (-9352) corresponds to Chrl: 108688478 ofmmS. 
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Gene s ecie Average MSF and Ml in tissue 
Placenta Blood cells Brain Heart Liver 
Human "0.295 (0.367) D ~ (0) (0) (0) 
APC Rhesus D.332 D.DD5 ： ： -
M o u s e I 0 I - I - I - I -
Human 0.387 (0.108) | • (0.267) (0.069) (0.007) 
CASPS Rhesus . 0.045 一 0 - 0 _ D.DD8 
M o u s e I - I - I - I -
H u m a n 丨[3.346 ((1139) | D 丨 （0) | (0.001) (0) 
DAB2SP Rhesus “ - - — ： ： -
Mouse 0 - - - -
H u m a n 0.845 (0.869) 0.042 〔0.847) (0.845) (0.658) 
PTPm Rhesus 0.532 0.03 - - -
Mouse 0.172 I - I - I - I -
H u m a n • .408 (0.653) 0.D15 (0) (0) (0) 
SCGB3A1 Rhesus 0.823 0.861 - ： -
M o u s e D.BSg - - - -
Human -
SERPiNBS Rhesus 0.549 0.959 - -
M o u s e D.437 - 0.795 11611 0.673 
Table 8.3. Summary of methylation status in tissues of human, rhesus monkey and mouse. 
The average MSF and average MI of TSGs in tissues of human, rhesus monkey and mouse are 
shown in the table. Average MSF was calculated by averaging the MSF of all the studied cases in 
each tissue. Average MI is shown in the bracket for reference. It was calculated by averaging the MI 
of all the studied cases in each human tissue from chapter 5. 
MSF, methylated site frequency; MI, methylation index 
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8.4 Discussion 
In this part of thesis, I investigated the methylation status of the hypermethylated TSGs 
in the placentas of the mouse and rhesus monkey. Hypermethylation of APC was 
observed in the rhesus monkey but not in the mouse. The conservation of placental Ape 
hypermethylation in the rhesus monkey once again supported the biological 
significance of this gene in the development of the primate placenta. However, when I 
further studied the methylation status of the other TSGs, I found that different genes 
could have different degree of cross-species conservation of placental methylation. 
While the hypermethylation of PTPN6 can be found in the rhesus monkey, no 
hypermethylation of CASP8 was observed even in the placenta of the rhesus monkey. 
Moreover, I found that the hypermethylation of SCGB3A1 was lost in the placenta of 
the rhesus monkey, i.e. methylation was found in tissues other than the placenta. Due to 
inconsistent conservation of TSG hypermethylation in the two animals, I studied the 
methylation status of SERPINB5 in these two animals. The data showed that the 
hypomethylation of SERPINB5 in the placenta is conserved both in the rhesus monkey 
and the mouse. 
The rhesus monkey is genetically closer to human, so it is perhaps not surprising that 
the placental epigenetics of the rhesus monkey is more similar to human than the mouse. 
From the phylogenetic studies, we know that human diverged from the rhesus monkeys 
about 25 million years ago (Stewart and Disotell 1998) and from mice about 65 million 
years ago (Kumar and Hedges 1998, Eizirik et al. 2001). Thus, the difference in time of 
divergence may explain the difference in methylation conservation of different animals. 
The degree of methylation in these genes may add another dimension for the study of 
molecular evolution. Thus, it would be interesting to investigate the methylation status 
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of these hypermethylated TSGs in the placentas of other placental mammals. 
The difference of methylation status of TSGs between primate and the mouse may also 
be explained by their structural difference. In terms of morphology, both the mouse and 
human placenta are classified as haemochorial. Thus, the murine placenta has 
commonly been studied as a model system for human placentation (Rossant and Cross 
2001). However, it is noteworthy that there are subtle differences between the murine 
and human placentas (Malassine et al. 2003). In fact, the former is more specifically 
classified as haemotrichorial whereas the latter is haemomonochorial in nature (Carter 
and Enders 2004). In light of this fact, it may not be surprising to see the epigenetic 
differences between the placentas of the two species as found in this study. Interestingly, 
a recent study also reported the lack of evolutionary conservation of imprinted genes 
between the extraembryonic tissues of the mouse and human (Monk et al. 2006). 
Although the functional differences between human and nonhuman primate placentas 
have also been reported (Golos 2004), the conservation of TSG hypermethylation 
suggests that the rhesus placenta may be a better model for studying the epigenetic 
mechanisms in the human placenta than that of the mouse (Golos 2004). 
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SECTION VI: CONCLUDING REMARKS 
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CHAPTER 9: Conclusion and future perspectives 
9,1 Pseudomalignant nature of placenta at the epigenetic level 
The placenta is a normal organ which exists in the interface between the fetus and its 
mother. It is important for providing nutrient and protection to the fetus. The multiple 
functions of placenta are achieved by its complex structure, which involves complicate 
developmental processes during placentation. The placenta exhibites rapid proliferation, 
invasion and migration and bears much similarity with a tumour (Soundararajan and 
Rao 2004). Thus, the placenta has been regarded as a pseudomalignant tissue — a normal 
tissue that share similar properties with that of a malignant one (Strickland and Richards 
1992). Our current understanding of the similarities between the placenta and malignant 
tissue are largely limited to the behavioural as well as the genetic level. In this thesis, I 
am interested in studying the similarity at the epigenetic level. 
Epigenetics is an emerging field in cancer biology (Jones and Laird 1999). It is found 
that many types of cancer are associated with the hypermethylation of TSGs (Feinberg 
and Tycko 2004). In this regard, in order to find the similarity of the placenta and 
malignant tissue at the epigenetic level, it would be useful to search for the existence of 
TSG hypermethylation in the placenta. 
In chapter 1, I systematically investigated the methylation status of 46 TSGs as well as 
15 non-TSGs. Five TSGs, namely, APC, CASP8, DAB2IP, PTPN6 and SCGB3A1 were 
found to be hypermethylated in the placenta but almost completely unmethylated in the 
maternal blood cells as revealed by bisulfite sequencing. The absence of 
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hypermethylation in non-TSGs suggested that the hypermethylation is more commonly 
found in the TSGs than non-TSGs of the placenta. 
To confirm the uniqueness of TSG hypermethylation in the placenta, I studied the 
methylation status of the five TSGs in chapter 2 using real-time MSP across 17 different 
normal tissues taken from two abortuses. My data suggested that three of the genes, 
APC, DAB2IP and SCGB3A1, were hypermethylated in the placenta only. This kind of 
tissue-specific methylation is different from the cell-type-specific methylation found to 
date. In chapter 3, the interesting methylation profile of APC was revealed using a 
method combining the use of methylation-sensitive restriction enzyme and the 
homogeneous MassEXTEND assay. I speculated that this kind of unique 
hypermethylation in the placenta may be important for the development of the primate 
placenta. 
9.2 Functional implication of TSG hypermethylation 
Promoter methylation is regarded as an epigenetic regulator for gene expression 
(Herman and Baylin 2003). Although the detailed mechanism is still unknown, it is 
considered important for gene silencing (Bird 1986). Hypermethylation of TSGs is a 
common phenomenon found in most types of cancer and the methylation is highly 
correlated to the silencing of the TSG in order to increase the growth advantages of the 
tumour (Baylin and Ohm 2006). In normal tissues, two classes of methylation have 
been observed in autosomal genes of normal cells. One of them is called 
cell-type-specific methylation. Although the exact function of this type of methylation 
remains to be confirmed, several studies suggested that it is responsible for silencing of 
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genes with cell-type-specific gene expression (Strathdee et al. 2004b). Another type of 
gene methylation in normal cells is called genomic imprinting (Bartolomei and 
Tilghman 1997). It is relatively well studied and believed to be involved in the silencing 
of one of the two alleles in a parent-of-origin manner. Current finding suggested that 
imprinted genes may be responsible for the nutritional supply from the placenta to the 
fetus (Constancia et al. 2004). 
The discovery of the interesting hypermethylated TSG in the placenta prompted me to 
explore the possible functional role of this phenomenon in the placenta. To do so, I tried 
to correlate it with the existing known methylation in normal cells, namely 
cell-specific-methylation and genomic imprinting. In chapter 2, the cross-tissue 
investigation on the methylation status of hypermethylated TSGs revealed that the 
methylation of CASP8 and PTPN6 could also be observed in the other tissues with 
CASP8 methylated in the brain and skeletal muscles while PTPN6 was found to be 
methylated in all of the epithelial tissues. These phenomena are in line with the 
cell-type-specific methylation which methylation can be found in several different cell 
types. However, I found no tissue other than the placenta which possesses the 
methylation of APC, DAB2IP and SCGBSAL The uniqueness of methylation in the 
placenta as observed in these genes distinguish them from the cell-type-specific ones. I 
further investigated the possibility of genomic imprinting in these TSGs using APC for 
demonstration in chapter 3. However, the data revealed an interesting methylation 
profile and required further investigation to confirm or exclude the possibility of 
genomic imprinting. 
In chapter 4, I studied whether TSG hypermethylation has a relationship with gene 
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expression. Using APC as a model, I found that the gene can be re-expressed after 
promoter demethylation. Thus, these results are consistent with the suggestion that the 
hypermethylation of APC is associated with expression in the placenta. The 
conservation of several TSG hypermethylation in the placenta of the rhesus monkey in 
chapter 5 further suggested that the hypermethylated TSGs might have important 
functional role in the placenta. 
9.3 Significance of hypermethylated TSGs in the placental evolution 
In chapter 5, I observed an unexpected result of methylation pattern difference in 
different species. Further, the conservation of hypermethylation in different TSGs is 
different. These lines of evidence suggested that the hypermethylated TSGs may have 
different roles in the placenta of different species. Epigenetics might therefore be an 
attractive approach for the study of placenta evolution. 
The placenta is essential for the success of mammalian reproduction. Intense selective 
pressure has shaped changes in placental anatomy and function during mammalian 
cladogenesis (Wildman et al. 2006). It is believed that the evolution of the placenta can 
reveal the evolutionary tree in placental mammals (Murphy et al 2001). Thus, the 
evolution of the placenta has attracted much attention from scientists. Early study of 
placenta evolution was based on concept of overall morphological similarity which 
results with many controversies (Luckett 1993). In the light of modem phylogenetics, 
the interrelationships between mammalian orders can be established with some certainty. 
The current molecular phylogenetic analysis is often carried out by examining the 
sequence variation between species on certain nuclear and mitochondrial genes 
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(Madsen et al. 2001, Murphy et al. 2001) or, very recently, on several retroposon 
elements (Nishihara et al. 2006, Murphy et al. 2007). However, none of these 
phylogeny is placental-specific. Consider the tissue-driven hypothesis of genome 
evolution (Gu and Su 2007), these markers may not truly reflect the history of placental 
evolution. Thus, the placental-specific methylated genes, like APC, maybe useful for 
the construction of the phylogenetic tree for placental evolution. 
In fact, several studies have revealed the important role of DNA methylation on 
mammal evolution. A comparative study on DNA methylation between the chimpanzee 
and human found that the CpGs in human brain are more methylated than in that of 
chimpanzees (Enard et al. 2004). This suggests that, at least in humans and 
chimpanzees, the methylation status of many CpG sites changes during the course of 
evolution and the difference between primates can be more profound than the difference 
in DNA sequence presented. Another strong piece of evidence comes from the DNA 
methylation profiling on human chromosomes (Eckhardt et al. 2006). By comparing the 
orthologous amplicons in human and the mouse, Eckhardt et al. found that the majority 
of the identified tissue-specific differentially methylated regions (T-DMR) were 
evolutionarily conserved. Taken together, the primate specific nature of TSG 
hypermethylation found in this study may suggest an important role on the evolution of 
the primate placenta and can be an attractive tool for the reconstruction of mammal 
phylogenetic tree that gives high resolution on the relationships between close relatives, 
essentially opening up a field of "placental phyloepigenetics". 
9.4 Clinical implication of TSG hypermethylation 
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Ten years ago, Lo et al discovered circulating fetal DNA in the plasma of pregnant 
women. This source of fetal DNA has opened up new possibilities for non-invasive 
prenatal diagnosis. Nowadays, several applications have been developed for the 
detection of conditions like sex-linked diseases (Costa et al. 2002), fetal rhesus D blood 
group status (Lo et al 1998), and (3-thalassaemia (Chiu et al. 2002). Many applications 
based on the quantitative aberrations in the concentrations of fetal DNA in maternal 
plasma have also been described for the detection of several pregnancy-associated 
disorders, including fetal trisomy 21 (Lo et al. 1999c), preeclampsia (Lo et al. 1999c), 
and preterm labour (Leung et al. 1998). 
Despite the promising use of plasma fetal DNA as a prenatal assessment tool, the lack of 
a universal fetal-specific DNA marker is still an obstacle for it to be used widely for 
clinical applications. The Y chromosome is commonly used as a fetal-specific marker in 
women carrying male fetuses (Lo et al. 1999a, Lo et al. 1999b). However, the use of 
such Y-specific markers has limited the application of this technology to half of 
pregnant women who are carrying male fetuses. 
Recently, a novel test for the detection of fetal DNA in maternal plasma using 
hypermethylated RASSFIA as a universal fetal marker has been developed (Chan et al 
2006b). Since the placenta is the main source of fetal DNA in the plasma of maternal 
circulation (Alberry et al. 2007), it is possible that APC, as well as the other 
hypermethylated TSGs found, can also be detected in the plasma of pregnant women. 
Many investigators have reported the elevation of circulating fetal DNA in maternal 
plasma of complicated pregnancies (Lo et al. 1999a, Lo et al. 1999b). By detecting the 
amount of hypermethylated TSGs sequences in the maternal plasma, it would be useful 
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to act as a non-invasive method to predict the pregnancy outcome. Indeed, significant 
difference of APC methylation is found between the sera of women with normal and 
complicated pregnancies (Muller et al. 2004). Further, the study of methylation status in 
the choriocarcinoma cell lines in chapter 5 revealed that there is an elevation of 
methylation of APC comparing with the normal placenta. Thus, it is possible that 
elevated level of methylation of APC in maternal plasma can be observed in the women 
with choriocarcinoma. Therefore, it can potentially be used as a non-invasion diagnostic 
marker for pregnancy diseases like choriocarcinoma. 
9.5 Future perspectives 
The discovery of hypermethylated TSGs in placenta of human and the rhesus monkey 
has opened up several lines of future research. 
First, it would be interesting to elucidate the functional role of hypermethylated TSGs in 
placental development. Although I have established a relationship between the 
methylation and gene expression of the TSGs in placenta which suggests a regulatory 
role of DNA methylation on gene silencing, the functional role of these 
hypermethylated TSGs in the biology and development of placenta remains to be 
studied. My findings that hypermethylation is present in the placenta of the rhesus 
monkey but not the mouse suggested that the rhesus monkey should be more 
appropriate for such functional studies. Besides, the time of establishment of this 
hypermethylation and its change in genomic reprogramming would also be interesting 
to investigate. 
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Second, the use of tissue-specific methylation as an epigenetic marker for phylogenetic 
tree construction would be another interesting line of study. The different degree of 
conservation on methylation of different genes in mammals offers interesting 
possibilities for constructing high resolution phylogenetic tree for placental mammals 
by combining the current information on genetics with that on epigenetics. Future work 
on this aspect should focus on finding out the degree of methylation conservation on 
these TSGs in different organs of primates. 
Last, but not the least, the non-invasive prenatal diagnostic application of these 
hypermethylated TSGs as universal fetal markers in maternal plasma would be worth 
pursuing. To do so, further confirmation of the existence of TSG hypermethylation in 
the circulating DNA of maternal plasma is necessary. Also, fetal specificity should be 
checked by comparing the existence of TSG hypermethylation in pre- and post-delivery 
plasma of pregnant women. To apply as indicators for complicated pregnancies, the 
possibility of aberrant epigenetic alterations in pregnancy-associated disorders should 
also be addressed. 
In summary, this thesis presented an exciting discovery of TSG hypermethylation in the 
placenta which may lead to several lines of interesting research in the future. The 
findings from this thesis have not only provided new insights into the current 
understanding of the epigenetics in the placenta, but also expanded the clinical as well 
as biological utility of these epigenetic markers for different applications. It is 
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